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Cell migration in physiology and disease 
 
Cell migration during embryogenesis 
 
Cell migration plays a central and pivotal role in a wide variety of biological 
phenomena. During embryogenesis, cellular migrations are a recurring theme in 
important morphogenic events, ranging from gastrulation to tissues formation. 
During gastrulation, for example, large groups of cells migrate collectively as 
sheets to form the resulting three-layers embryo. Subsequently, cells migrate from 
various epithelial layers to target locations, where they then differentiate to form 
the specialized cells that make up different tissues and organs. Among several, a 
well-studied example comes from the neuronal development. The correct 
positioning of neurons during development, achieved through directed migration, 
is the basis for proper brain function. After closure of the neural tube at an early 
embryonic stage, the most anterior part of the tube becomes an enlarged vesicle 
called the prosencephalon. The wall of this structure is composed of one 
continuous sheet of neuroepithelial cells that will give rise to all of the structures 
in the forebrain including the cerebrum, hippocampus, and thalamus. Cortical 
neurons arise from the proliferative pseudostratified epithelium at the margin of 
the embryonic cerebral ventricles. During each cell cycle, the progenitor cells 
undergo a distinctive pattern of oscillation in the ventricular zone, termed 
interkinetic nuclear migration. Cells undergo S phase at the basal surface of the 
ventricular zone and mitosis at the apical surface. Concurrently, cells begin to 
undergo asymmetric cell division, and the fraction of cells that begin to 
differentiate into neurons increases, whereas the proportion of cells remaining as 
progenitors decreases. Toward the end of cortical development, the majority of 
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neural progenitors give rise to two daughter cells that differentiate into neurons, 
leading to the eventual depletion of neural precursors. Once a cell has exited the 
cell cycle, it must migrate out of the ventricular zone toward its final resting place 
in the developing neocortex (Ayala et al., 2007).  Other examples of migration 
during embryonic development are the movements and fusions of epithelial cells, 
essential morphogenetic events in both vertebrate and invertebrate systems. Many 
of these processes, such as ventral enclosure in Caenorhabditis elegans 
(Williams-Masson et al., 1997), embryonic dorsal closure (Jacinto et al., 2000) 
and imaginal disc fusion in Drosophila melanogaster (Martín-Blanco et al., 
2000), neural tube (Jean-FranÁois and Gary, 2001) and palate closure in 
vertebrates, involve extensive and directed movements of two epithelial faces. 
During the later stages of mouse embryonic and post-natal development, the 
eyelid closure is another important model of epithelial migration. The 
development of mouse eyelid starts at E13.5 (embryonic, days post coitum) with 
eyelid folds that extend over the cornea and move towards the center of the eye; 
eyelid closure is accomplished at E15.5-E16.5. This process is followed by the 
fusion of the eyelid epidermis to form a closed eyelid that covers the ocular 
surface and serves as a protective barrier crucial for normal eye development 
(Findlater et al., 1993) (Figure 1). Although the initial eyelid formation and 
growth requires the proliferation of epithelial cells, its closure depends on the 
movements of the epithelial sheets rather than on cell proliferation and death. As 
will be discuss later, the underlying cellular and molecular mechanism involved in 
the epithelial sheets fusion relies on the dynamics of the actin cytoskeleton.  
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Figure 1. Eyelid formation and fusion during mouse development. 
 
 
Cell migration in the adult life: the example of cutaneous wound healing 
 
Migration remains prominent in the adult life, in normal physiology as well 
as during pathological conditions. In the inflammatory response, for example, 
leukocytes migrate into areas of insult, where they mediate phagocytic and 
immune functions. Migration of keratinocytes, fibroblasts and vascular 
endothelial cells is essential for wound healing. Re-epithelialization of wounds 
begins within hours after injury. Epidermal cells from skin appendages such as 
hair follicles quickly remove clotted blood and damaged stroma from the wound 
space. At the same time, the cells undergo marked phenotypic alterations that 
include retraction of intracellular keratins, dissolution of inter-cellular 
desmosomes, which provide physical connections between the cells and formation 
of peripheral cytoplasmic actin filaments, which allow cell movement (Paladini et 
al., 1996). Furthermore, epidermal and dermal cells no longer adhere to one 
another, because of the dissolution of hemidesmosomal links between the 
epidermis and the basement membrane, which allows the lateral movement of 
epidermal cells (Gabbiani et al., 1978; Goliger and Paul, 1995). The expression of 
integrin receptors on epidermal cells allows them to interact with a variety of 
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extracellular-matrix proteins (e.g., fibronectin and vitronectin) that are 
interspersed with stromal type I collagen at the margin of the wound and 
interwoven with the fibrin clot in the wound space (Larjava H et al., 1993). The 
migrating epidermal cells dissect the wound, separating desiccated eschar from 
viable tissue. The path of dissection appears to be determined by the array of 
integrins that the migrating epidermal cells express on their cell membranes. The 
degradation of the extracellular matrix, which is required if the epidermal cells 
need to migrate between the collagenous dermis and the fibrin eschar, depends on 
the production of collagenase by epidermal cells, as well as on the activation of 
plasmin by plasminogen activator produced by the epidermal cells in order to 
facilitate the degradation of collagen and extracellular-matrix proteins (Pilcher et 
al., 1997). One to two days after injury, epidermal cells at the wound margin 
begin to proliferate behind the actively migrating cells. The stimuli for the 
migration and proliferation of epidermal cells during re-epithelialization are 
several. The absence of neighbor cells at the margin of the wound (the “free edge” 
effect) may signal both migration and proliferation of epidermal cells. Local 
release of growth factors and increase expression of growth-factor receptors may 
also stimulate these processes. Known growth factors are epidermal growth factor 
(EGF), transforming growth factor alpha (TGF-α) (Nanney and King, 1996), and 
keratinocyte growth factor (KGF) (Werner et al., 1994). As re-epithelialization 
proceeds, basement membrane proteins reappear in a very ordered sequence from 
the margin of the wound inward, in a zipper-like fashion. Epidermal cells revert to 
their normal phenotype, once again firmly attaching to the re-established 
basement membrane and underlying dermis. 
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Cancer metastasis 
 
In the early phases of multi-step progression of solid tumors, cancer cells 
multiply around the site where the initial cancer cell originated and first began the 
uncontrolled proliferation. Such primary tumor eventually increases in size and 
may locally infiltrate and invade. This uncontrolled proliferation in the primary 
site is ultimately responsible for only 10% of the deaths from cancers. The 
remaining approximately 90% of the deaths originate by cancerous growth far 
away from the primary tumor site, these cancers in secondary sites are called 
metastases. Metastases are formed by cancer cells that acquire a migratory and 
invasive phenotype and are capable of leaving the primary tumor mass and 
disseminate through blood and lymphatic vessels in secondary organs or lymph 
nodes. The so called “invasion-metastasis cascade” ascribes six different steps to 
the overall process (Figure 2). It starts with tumor cell proliferation and localized 
invasion in the surrounding stroma. For breast cancers, this localized invasion 
enables in situ carcinoma cells to breach and disrupt the basement membrane. 
Thereafter, the invasive cells may intravasate in lymphatic or blood microvessels, 
allowing the transportation through circulation and the dissemination of cancer 
cells to distant anatomical sites. The migrated cancer cells may extravasate and 
form a micrometastasis in the secondary site. Eventually, some of them may 
acquire the ability to colonize and grow in the secondary site and form a 
macrometastasis (Fidler, 2003). The metastatic cascade is thought to be a very 
inefficient process. Tens of thousands of cancer cells can be shed into the 
circulation every day, yet less than 0.01% of these will survive to produce 
metastases (Chambers et al., 2002). It is intuitive that cell motility and 
deregulation of it is the (or one of the) fundamental process that allows the 
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formation of metastases. The capacity to disseminate could be intrinsic to certain 
pre-malignant cell lineages. It has long been recognized that many normal cell 
types are involved in complex migratory and invasive behaviors during 
development and adulthood. For example, normal epithelial cells are motile. In 
the mammary gland, the invasive and migratory mechanisms that underlie the 
branching morphogenesis of normal epithelial cells also regulate the formation of 
mammary hyperplasia (Ewald et al., 2008). Together with the long standing 
notion that the phenotype of cancer cells is dictated by their genome and that the 
tumorigenesis is essentially a cell-autonomous phenomenon, the other component 
that plays a significant role in the induction of cell growth and metastasis is the 
tumor microenvironment. As it will be discussed in greater detail later, the tumor 
microenvironment shapes and is a potent inductor of cancer metastasis (Joyce and 
Pollard, 2009a).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The invasion-metastasis cascade The invasion-metastasis cascade ascribes six distinct 
steps to the overall process. The initial step of localized invasiveness enables in situ carcinom cells 
to invade the surrounding stroma. Thereafter, they may intravasate into either lymphatic or blood 
microvessels. The latter may then transport these cancer cells to distant anatomical sites, where 
they may extravasate and form dormant micrometastases. Eventually some of the micrometastases 
may acquire the ability to colonize the tissue in which they have landed, enabling them to form a 
macroscopic metastasis. The last step, colonization, seems to be the most inefficient of all. The 
small probability of successfully completing all steps of this cascade explains the low likelihood 
that any single cancer cell leaving a primary tumor will succeed in becoming the founder of a 
distant, macroscopic metastasis. Adapted from I.J. Fidler, Nat. Rev. Cancer 3:453–458, 2003 
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Mechanisms of cell migration 
 
With a major focus on cell motility in a 2D substrate, the present 
understanding of cell migration is a composite derived from studies of different 
cell types and environments. In general, cell migration can be usefully 
conceptualized as a cyclic process (Lauffenburger and Horwitz, 1996). The initial 
response of a cells plated on matrix-coated surfaces to a migration-promoting 
agent is the polarization of the cell body and the extension of protrusions in the 
direction of migration. These protrusions can be branched filaments leading to 
sheet-like protrusions (lamellipodia) or long parallel or bundled finger-like 
protrusions (filopodia), and are usually driven by actin polymerization and are 
stabilized by adhering to the extracellular matrix (ECM) or adjacent cells via 
transmembrane receptors linked to the actin cytoskeleton. These adhesions serve 
as traction sites for migration as the cell moves forward over them, and they are 
disassembled at the cell rear, allowing it to detach. Carcinoma cells cultured on 
top of dense ECM form invadopodia, specialized actin-rich structures that 
protrude into the matrix and secrete proteases focally that degrade the matrix.  
 
Cell polarization 
 
The first step of cell migration is a morphological polarization that the cell 
must acquire in order to generate intracellular forces that produce a net body 
translocation. This means that the molecular process that acts at the front of the 
cell is different compared to the one on the back. A master regulator of cell 
polarity in eukaryotic organisms, ranging from yeast to humans, is Cdc42 
(Heasman and Ridley, 2008). Cdc42 is a member of the Rho GTPases family 
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proteins, which switch between an active GTP-bound form and an inactive GDP-
bound form. The cycle is regulated by guanine nucleotide-exchange factors 
(GEFs), which activates Rho GTPases by promoting the release of GDP and the 
binding of GTP and GTPase-activating proteins (GAPs), which inactivate Rho 
GTPase by increasing the intrinsic GTPase activity of Rho proteins. Cdc42 is 
activated toward the front of migrating cells and, together with Rac and RhoG, is 
the main activator of the WASP/WAVE-Arp2/3 complex pathway, leading to the 
formation of a branched actin network and extension of lamellipodia. Another 
important role of Cdc42 for cell polarity is the active localization of the 
microtubule-organizing center (MTOC) and Golgi apparatus in front of the 
nucleus, toward the leading edge. The MTOC and Golgi polarization may be 
needed for the microtubule-mediated delivery of vesicles to the leading edge, 
providing proteins important for cell protrusion (Etienne-Manneville and Hall, 
2002). 
 
Membrane protrusion and the protrusive machinery 
 
The extension of both lamellipodia or filopodia in response to migratory 
stimuli is almost universally found to be associated with local actin 
polymerization (Condeelis, 1993). Actin filaments are intrinsically polarized with 
fast-growing "barbed" ends and slow-growing "pointed" ends, and this inherent 
polarity is used to drive membrane protrusion. The presence of free barbed ends 
act as template for new polymerization. To initiate actin assembly, free barbed 
ends can be created by three general mechanisms: uncapping of pre-existing 
filaments, severing of filaments (Condeelis, 2001) or de novo nucleation (Welch 
and Mullins, 2002a). Studies with permeabilized platelets indicate that uncapping 
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of barbed ends capped by capping protein (CP) is the primary mechanism for the 
production of free barbed ends in response to thrombin stimulation (Hartwig et 
al., 1995). Polyphosphoinositides, including PIP2, can bind to CP and inhibit its 
capping activity also causing rapid uncapping. One attractive hypothesis is that 
PIP2 generated in the membrane helps to inhibit capping by CP near the 
membrane, at the site of protrusion. A second mechanism for the generation of 
free barbed ends in vivo is the severing of pre-existing filaments. The two proteins 
that have been studied most extensively in this regard are gelsolin and cofilin. 
Gelsolin severs filaments in a Ca++ dependent step and caps the barbed end of the 
filament fragment at the severed site. To generate free barbed ends, gelsolin must 
be released from the barbed end in a subsequent uncapping step, which can be 
accomplished in vitro by removal of Ca++ from, and the binding of 
phosphoinositides to, gelsolin (Hartwig et al., 1995). The ADF/Cofilin family of 
proteins nucleates actin polymerization by severing filaments to generate free 
barbed ends. As cofilin does not remain bound to the barbed end of the filament at 
the severed site, severing produces free barbed ends directly. As long as 
monomeric actin (G-actin) is present and unsequestered at concentrations 
sufficient to support polymerization (1 µM), severing will result in nucleation. 
When the concentration of G-actin is limiting, the net result of severing by cofilin 
is depolymerization, not nucleation. When cofilin and actin are present in near-
equimolar concentrations, severing, increased off-rate and sequestering can cause 
the treadmilling of the actin filaments population (Carlier et al., 1997). Because 
cofilin is essential for cell viability and can increase the rate of actin 
polymerization, depolymerization and barbed ends number, it has been proposed 
as a potential dominant player in generating actin polymerization transients in 
vivo (Bamburg, 1999).  
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Another general model of generation of free barbed ends is de novo nucleation by 
the Arp2/3 complex as the nucleation template. As discussed before, the 
organization of filaments depends on the type of protrusion (lamellipodia vs 
filopodia). Actin polymerization in lamellipodia is mediated by the Arp2/3 
complex, which binds to the sides or tip of a preexisting actin filament and 
induces the formation of a new daughter filament that branches off the mother 
filament (Welch and Mullins, 2002b). Activation of the Arp2/3 complex is 
localized by WASP/WAVE family members, which are themselves activated at 
the cell membrane. Pushing of the membrane, the actual protrusive event is 
believed to occur not by elongation of the actin filament per se but by an "elastic 
Brownian ratchet" mechanism, in which thermal energy bends the nascent short 
filaments, storing elastic energy. Unbending of an elongated filament against the 
leading edge would then provide the driving force for protrusion (Pollard and 
Borisy, 2003). As mentioned before, small Rho GTPases are central regulators of 
protrusions. Cdc42 and Rac can both activate N-WASP/WAVE proteins and in 
turn regulate Arp2/3 activity. Extracellular chemotactic stimuli can activate 
through receptors and the ras signaling the phosphoinositide 3-kinase (PI3K) and 
the phosphatase PTEN (phosphatase and tensin homolog), key signaling proteins 
supposed to work as gradient amplifiers. PI3K and PTEN catalyze the production 
and degradation of phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3; 
referred as PIP3) at the plasma membrane, resulting in a net accumulation of PIP3 
at the leading edge (Kolsch et al., 2008). The accumulation of PI3K and PIP3 at 
the leading edge activates several molecules important for cell migration. PI3K 
products activate Rac GEFs, once Rac is active it activates several feedback loops 
that are aimed to potentiate the directional protrusion. First, Rac itself stimulate 
the recruitment of PI3K at the plasma membrane (Srinivasan et al., 2003); second 
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Rac may stabilize microtubule and in turn be activated by microtubule 
polymerization (Rodriguez et al., 2003); third Rac is activated and localizes at 
plasma membrane after integrin engagements, so new adhesions formed at the 
leading edge will stimulate Rac (Kiosses et al., 2001). Several actin-binding 
proteins regulate the rate and organization of actin polymerization in protrusions 
by affecting the pool of available monomers and free ends. For example, profilin 
prevents self-nucleation by binding to actin monomers and also serves to 
selectively target monomers to barbed ends. Filament elongation is terminated by 
capping proteins, thereby restricting polymerization to new filaments close to the 
plasma membrane. In addition, disassembly of older filaments, which is needed to 
generate actin monomers for polymerization at the front end, is assisted by 
proteins of the ADF/cofilin family, which sever filaments and promote actin 
dissociation from the pointed end. Other proteins play supporting roles in the 
dendritic network: cortactin stabilizes branches, whereas filamin A and α-actinin 
stabilize the entire network by cross-linking filaments (Welch and Mullins, 
2002a). Filopodial protrusion is thought to occur by a filament treadmilling 
mechanism, in which actin filaments within a bundle elongate at their barbed ends 
and release actin monomers from their pointed ends (Welch and Mullins, 2002a). 
The long and unbranched filament organization is consistent with assembly 
occurring by elongation rather than by branched nucleation. Many proteins are 
enriched at filopodial tips, including Ena/VASP proteins, which bind barbed ends 
of actin filaments and antagonize both capping and branching, thereby allowing 
continuous elongation of filaments, and fascin, which bundles actin filaments and 
might thereby generate the stiffness needed to allow efficient pushing of the 
plasma membrane in filopodia (Welch and Mullins, 2002a). The geometric design 
of lamellipodia and filopodia endows them with the capacity to perform distinct 
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functions. Through localized activation of the Arp2/3 complex, the lamellipodium 
could be induced to grow in a particular direction, providing the basis for 
directional migration. In contrast, filopodia, with their parallel bundle 
organization, are particularly well designed to serve as sensors and explorers the 
local environment, acting as sites of signal transduction, and attaching to 
extracellular matrix (Davenport et al., 1993). Contained within filopodia are 
receptors that detect cues from the microenvironment (Lidke et al., 2005), and 
initiate downstream signaling pathways leading to cellular responses. Filopodia in 
neuronal growth cones orient toward gradients of guidance cues, an event that 
precedes the extension, turning or branching of the growth cone neurite towards 
chemoattractants (Bentley and Toroian-Raymond, 1986). Filopodia appear to be 
essential for neurite initiation and filopodia function may be needed for the 
establishment of neural circuitry (Smith, 1994). Similarly, filopodia are central in 
the proper alignment and attachments of cell during the dorsal closure in 
Drosophila embyo (Jacinto et al., 2000) and in a process known as “adhesion 
zippering” which occurs in epithelial sheet fusion in Caenorhabditis Elegans 
(Raich et al., 1999) and in cultured cells (Vasioukhin et al., 2000). Two 
mechanisms that use actin-nucleating proteins have been proposed for filopodia 
formation. In the “convergent elongation” model (Svitkina et al., 2003) filopodia 
are initiated by F-actin regulators including Arp2/3 complex-mediated nucleation 
downstream of Cdc42, Ena/VASP at filopodial tips, and fascin along the shafts, 
whereas the opposing model proposes that mDia2 performs most of these 
functions (Pellegrin and Mellor, 2005). 
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Formation and stabilization of attachments 
 
For a migration to occur, a protrusion must form and then stabilize by 
attaching to the surrounding matrix. Integrins are the major family of migration-
promoting receptors and may act as “feet” of a migrating cell supporting adhesion 
on ECM. Integrins link ECM to the actin cytoskeleton and may activate signaling 
cascades, so integrins are molecules that allow an “inside-out signaling”. Integrins 
are heterodimeric receptors with large ligand-binding extracellular domains and 
short cytoplasmic domains. The binding of ligands confers conformational 
changes in the receptor that leads to receptor clustering, that initiate intracellular 
signaling such as protein phosphorylation, activation of small GTPases, change in 
phospholipids biosynthesis. This is linked to formation and strenghting of 
adhesion sites and organization and dynamics of the actin cytoskeleton (Geiger et 
al., 2001). Integrins affinity is regulated by alterations in the conformations of the 
extracellular domains that result from interactions at the integrin cytoplasmic tail. 
Talin is a component of adhesion plaques and interacts with integrin cytoplasmic 
tails (Horwitz et al., 1986), modulating the receptor affinity. The mechanism by 
which adhesions assemble in migrating cells is still not well understood. It may 
starts with little focal contacts, dependent on Cdc42 and Rac that stabilize the 
lamellipodium by mediating attachments to ECM. 
 
Tractional forces 
 
A migrating cell must be able to protrude and then detach from the older 
adhesions in order to move. By connecting the ECM to the intracellular 
cytoskeleton, integrins serve as both traction sites over which the cell moves and 
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as mechanosensors, transmitting information about the physical state of the ECM 
into the cell and altering cytoskeletal dynamics (Galbraith et al., 2002). The force 
transmitted to sites of adhesion derives from the interaction of myosin II with 
actin filaments that attach to these sites. Myosin II activity is regulated by myosin 
light-chain (MLC) phosphorylation, which is either directly positively regulated 
by MLC kinase (MLCK) or Rho kinase (ROCK) or negatively regulated by MLC 
phosphatase, which is itself phosphorylated and inhibited by ROCK. Whereas 
MLCK is regulated by intracellular calcium concentration as well as by 
phosphorylation by a number of kinases, ROCK is regulated by binding Rho-GTP 
(Riento and Ridley, 2003). MLC phosphorylation activates myosin, resulting in 
increased contractility and transmission of tension to sites of adhesion. 
 
Retraction at the rear 
 
At the rear of migrating cells, adhesions must also disassemble. The cell 
rear is a region where integrin-cytoskeletal linkages tend not to form and the 
membrane is not well supported by the cytoskeleton network. Rho GTP-ases are 
more active in the cell rear than in the front and it regulates negatively Rac 
activity. The Rho/ROCK/MLC/Myosin II pathway is implicated in the high 
tension exerted on the rear adhesions and contributes to the detachments 
(Lauffenburger and Horwitz, 1996; Riento and Ridley, 2003).  
 
How does a cancer cell migrate in vivo? 
 
Although our current understanding of cell migration and movements comes 
from studies performed in 2D environments, when we consider a migrating cell in 
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3D environments, such in a tissue, an additional component is the proteolitic 
remodeling of the extracellular matrix (ECM) and in other cases, the ability of a 
cell to change in shape in order to squeeze through the gaps in the ECM. 
Advances in intravital imaging techniques, together with fluorescent proteins 
technology are shedding the light on the mode of motility of cancer cell in their 
microenvironment. Intravital multiphoton microscopy combines the advanced 
optical techniques of laser-scanning microscopy with long-wavelength 
multiphoton fluorescence excitation to capture high-resolution, three-dimensional 
images of living tissues that have been tagged with highly specific fluorophores 
and now make it possible to directly observe cell behavior in primary tumors in 
live animals (Condeelis and Segall, 2003). These advances in the ability to image 
cells in primary tumors have stimulated hypotheses about the mechanisms of cell 
migration during invasion and intravasation, and provided new insights about the 
microenvironment that is required for these key steps in metastasis. Tumor cells 
can infiltrate neighboring tissue matrices in diverse patterns. They can 
disseminate as individual cells, adopting a mesenchymal motility or expand in 
solid cells strands, sheets, files or clusters, adopting a collective cell migration. 
Some carcinoma cells move with an amoeboid morphology, a kind of motility 
similar to the one that Dictyosteliun discoideum adopts (Friedl and Wolf, 2003). 
The speed and character of cell motility in vivo is quite different from that 
normally observed on two-dimensional substrates in vitro (Condeelis and Segall, 
2003). In vivo, cancer cells move at high speeds (up to 15 µm a minute) and can 
change shape and direction rapidly in a manner similar to some leukocytes. This 
type of motility is usually termed amoeboid motility and uses preferentially cycles 
of actin polymerizations, cell adhesion and acto-myosin contraction. The Arp 2/3 
complex and cofilin pathways are up-regulated in mammary tumor cells in vivo 
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(Wang et al., 2004; Wang et al., 2006) and are key players for the starting of 
productive migrations. Following the extension of a protrusion by a motile cell, 
adhesions are formed to the ECM and a dense network of collagen fibers around 
the margin of most tumors can be visualized. Moving tumor cells make contacts 
with collagen fibers and frequently move along fibers (Wyckoff et al., 2000). 
However, the large focal adhesions characteristic of cell-matrix interactions in 
vitro are not observed as motile cells contact collagen fibers in vivo. Focal 
adhesions usually take many minutes to mature, and this length of time is not 
compatible with fast moving cells that can travel their entire length in 2-3 
minutes. Once new attachments to the ECM have been formed, acto-myosin 
interactions cause contractile forces that result in movement of the rest of the cell 
body. In vivo multiphoton confocal imaging of motile tumor cells expressing 
myosin light chain fused to GFP revealed that the acto-myosin network is largely 
cortical and not organized in 'stress-fibers' as seen in two-dimensional 
environments in vitro (Wyckoff et al., 2006). This cortical acto-myosin is largely 
controlled by the Rho-associated coiled-coil containing kinases (ROCK). 
Contraction of cortical acto-myosin can also generate points of constriction in the 
cell body that enable cells to squeeze between and around collagen fibers. These 
constrictions are typically around 5 µm in diameter. Squeezing between collagen 
fibers abrogates the requirement to cleave the fibers (Wolf et al., 2003). 
Correspondingly, inhibition of matrix metalloproteinases (MMPs) does not stop 
amoeboid cancer cell movement in vivo, demonstrating how the plasticity of 
cancer cell movement (from mesenchymal to amoeboidal) can negate the efficacy 
of anti-invasion drugs. Mammary tumor cells often migrate in a common 
direction consistent with the existence of chemotactic gradients, presumably EGF 
secreted by tumor-associated macrophages (Wyckoff et al., 2004). The ability of 
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cells to orient themselves with respect to blood vessels may be specific to 
metastatic cells. Two studies have shown that even when non-metastatic cells 
began to intravasate, they frequently became fragmented by shear stress (Wyckoff 
et al., 2000) and conversion of cells that normally move with an elongated 
morphology to a more rounded morphology increased both their ability to move 
and to enter vessels (Sahai et al., 2007). Together, these studies suggest that tumor 
cells with an elongated morphology may need to adopt a more rounded shape to 
efficiently intravasate and withstand shear stresses within blood vessels. It is 
tempting to speculate that the increased cortical acto-myosin contraction that 
promotes the rounded morphology may also enable the cortical cytoskeleton to 
withstand greater mechanical stress.  
 
Role and Ena/VASP proteins in cell migration 
 
Ena/VASP proteins have emerged as important regulators of actin assembly 
and cell motility in a variety of organisms and cell types. Drosophila Enabled 
(Ena), was discovered in a genetic screen for dominant suppressors of Drosophila 
Abelson tyrosine kinase (D-Abl) mutants (Gertler et al., 1990). VASP was 
discovered as protein substrate for cAMP and cGMP-activated kinases in platelets 
(Haffner et al., 1995), while EVL was identified together with Ena using a probe 
from Drosophila Ena used to isolate the Ena murine cDNAs (Gertler et al., 1996). 
Ena/VASP proteins are a structurally conserved family found in vertebrates, 
invertebrates and Dictyostelium discoideum. It consists of Drosophila Ena, C. 
elegans Unc-34, Dictyostelium VASP, and the three mammalian family members 
VASP, Mena, and EVL. All Ena/VASP family members share a conserved 
tripartite domain structure (Figure 3): an amino-terminal Ena/VASP homology 1 
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(EVH1) domain followed by a proline-rich central region and a carboxy-terminal 
Ena/VASP homology 2 (EVH2) domain. Mena is the only member of the family 
to have a long stretch of highly charged basic and acid amino acids (LERER). 
This insertion might adopt an extended helical structure and confer a further 
binding-binding interface and flexibility to the molecule.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Domains and functional organization 
 
The EVH1 domain belongs to the pleckstrin-homology (PH) domain 
superfamily but unlike PH domains, EVH1 domains do not appear to bind to 
phosphatidylinositol lipids. Instead, the EVH1 domain, similar to PTB domains 
(another branch of the PH domain superfamily), binds to peptide ligands with 
high affinity. The EVH1 domains appear to bind to peptides containing a poly-
Figure 3. Organization of Ena/VASP proteins. The domains and protein interaction sites are 
shown in the schematic. Phosphorylation sites are also indicated. Adapted from Drees & 
Gertler, Curr Opin Neurobiol. 2008 Feb;18(1):53-9 
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proline II helix, a left-handed helix with three residues per turn (Prehoda et al., 
1999). EVH1 domains use a conserved hydrophobic cleft to bind a four-residue 
motif containing 2-4 prolines. Conserved aromatic residues, including an invariant 
tryptophan, create a wedge-shaped groove on the EVH1 surface that matches the 
triangular profile of a polyproline type II helix. Hydrophobic residues adjacent to 
the polyproline motif dock into complementary sites on the EVH1 domain to 
enhance ligand-binding specificity. Flanking residues in the vicinity of the PPII 
helix confer specificity of binding to SH3, WW, and EVH1 domains. The EVH1 
domain in Ena/VASP proteins binds to the consensus site 
(F/W/Y/L)PPPPX(D/E)(D/E)(D/E) φ (X=any amino acid, φ=hydrophobic amino 
acid). Functional binding sites for EVH1 domains are found in zyxin (Drees et al., 
2000), vinculin (Brindle et al., 1996), Fyb/SLAP (Krause et al., 2000), the 
Drosophila and C. elegans axon guidance receptor Robo/Sax-3 (Bashaw et al., 
2000), and in the ActA protein of Listeria monocytogenes (Niebuhr et al., 1997). 
EVH1 domain recruits Ena/VASP proteins to specific sites within the cell. 
Ena/VASP proteins are recruited to focal adhesions by zyxin and vinculin, to 
phagocytic cups of macrophages and the contact site of T cells with antigen-
presenting cells by Fyb/SLAP, and to Listeria tail by ActA. Other proteins such as 
palladin (Mykkanen et al., 2001), migfilin (Tu et al., 2003), human FAT (Moeller 
et al., 2004), RIAM (Lafuente et al., 2004) and Lamellipodin (Krause et al., 2004) 
also harbor putative EVH1-binding sites. In particular, Lamellipodin has a PH 
domain that binds specifically to PIP2 and is sufficient for plasma membrane 
recruitment upon treatment with PDGF. Since often phosphatidylinositol lipid 
products of PI-3 kinase, PI(3,4,5)P3 and its metabolite PI(3,4)P2 are downstream 
mediators of chemotactic receptors, Lamellipodin can be the link between 
extracellular chemotactic stimuli and Ena/VASP, since it was shown to be 
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responsible for Ena/VASP recruitment to the leading edge (Krause et al., 2004). 
Recently, a new EVH1 binding-protein as been identified by Michael Way lab. 
TES is a putative human tumor suppressor gene at 7q31.2, a chromosomal region 
that is frequently deleted in hematopoietic malignancies and epithelial tumors 
(Tobias et al., 2001). Although Tes doesn’t contain any FPPPP motifs, it is shown 
to bind specifically Mena and not EVL or VASP. The LIM3 domain of Tes binds 
to the residues A12 adjacent to F32, and residues such as I53 in the ß3- ß4 loop of 
Mena’s EVH1 domain. Moreover, Tes regulates Mena-dependent but not EVL or 
VASP-dependent cell migration (Boeda et al., 2007). This is an intriguingly 
finding, since in mammary tumor cells, Tes is downregulated while Mena is 
upregulated (Di Modugno et al., 2004; Di Modugno et al., 2006; Wang et al., 
2004; Wang et al., 2007) and one could envisage that Tes may somehow regulate 
Mena and its lost may also contribute to a Mena-dependent tumor invasion. 
The proline-rich domain harbors binding sites for SH3 and WW domain-
containing proteins and the actin monomer-binding protein profilin. This region is 
the most divergent within the family and therefore may have different binding 
partners and mechanisms of regulation. Ena binds to the SH3 domains of Abl, 
Src, and the carboxy-terminal SH3 domain of Drk (Ahern-Djamali et al., 1999; 
Gertler et al., 1995). Similarly, EVL binds to the SH3 domains of Lyn, N-Src, 
Abl, and the WW domain of FE-65 (Lambrechts et al., 2000). In contrast, Mena 
does not bind to the SH3 domain of N-Src, but is bound by the SH3 domain of 
IRSp53 (Krugmann et al., 2001), Abl, Arg, Src (Gertler et al., 1996), and the WW 
domain of FE65 (Ermekova et al., 1997). So far, it is not clear which is the 
fisiological role of the interaction of Ena/VASP with several or proline-rich 
binding partners. All Ena/VASP family members contain proline-rich-binding 
sites for the small G-actin-binding protein profilin, and this binding is 
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independent of their phosphorylation status (Ahern-Djamali et al., 1999; Gertler et 
al., 1996; Lambrechts et al., 2000). Since the majority of actin is complexed to 
profilin in the cell (this is needed to avoid spontaneous nucleation of actin), the 
binding of profilin-actin complexes by Ena/VASP can explain, at least in part, the 
contribution of this protein family to actin-dependent processes. A model for 
binding of profilin-actin has been shown recently. Ena/VASP binds to profilin-G-
actin complexes through two interfaces simultaneously, a profilin:Ena/VASP 
interface and a G-actin:Ena/VASP interface. The G-actin in the profilin-G-actin-
Ena/VASP complex is oriented towards the F-actin binding motif of Ena/VASP; it 
is presumably positioned in this way to facilitate its addition to growing filaments. 
In fact, the poly-proline region of VASP contains three different modules: a 
regulatory site, a recruiting site and a loading site for profilin:actin (Ferron et al., 
2007). The model for the elongation machinery shows three steps of the 
elongation mechanism: 1) recruitment of profilin–actin to the poly-Pro regions, 2) 
loading of profilin–actin from the last poly-Pro site onto the G-actin binding 
domain in the EVH2 domain and 3) filament elongation resulting from the 
addition of the actin subunit at the barbed end and the release of profilin (Figure 
4). 
The EVH2 is the “business” domain of Ena/VASP. It contains the necessary 
for the regulation of actin dynamics: starting from the amino terminus, a G-actin-
binding site, an F-actin-binding site, and a coiled-coil motif required for 
oligomerization (Bachmann et al., 1999; Gertler et al., 1996). The G-actin-binding 
site resembles a motif in the small actin-monomer-binding protein ß-thymosin 
(Gertler et al., 1996) and is required for the in vitro actin nucleation activity of 
VASP (Birgit et al., 2002). The second conserved block in the EVH2 domain of 
VASP can co-sediment and bundle F-actin at low salt conditions (Bachmann et 
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al., 1999; Huttelmaier et al., 1999). The third conserved block consists of a coiled-
coil structure that mediates oligomerization of Ena/VASP proteins (Bachmann et 
al., 1999; Zimmermann et al., 2002). VASP behaves as a tetramer, and the coiled-
coil motif is sufficient to mediate tetramer formation. Furthermore, co-
immunoprecipitation and yeast two-hybrid analysis indicate that homo- and hetero 
tetramerization among the members of the Ena/VASP family can also be observed 
in vivo (Ahern-Djamali et al., 1999). The coiled-coil sequence of VASP has been 
analyzed by crystalloghraphy (Kuhnel et al., 2004). It tetramerizes in parallel with 
an unusual right-handed coil raising the interesting possibility that this forms a 
structural interface for binding to barbed ends of F-actin (which also forms a 
right-handed coil). The EVH2 domain alone is sufficient to fully complement the 
function of full-length Ena/VASP in Ena/VASP deficient cells. Interestingly, 
tetramers formation is very important for Ena/VASP in order to exploit the 
function, since deletion of the coiled-coil domain doesn’t rescue the phenotype in 
the deficient cells (Loureiro et al., 2002). Recently, the sequence between the F-
actin binding domain and the tetramerization domain as been found to be 
important for the capture of barbed ends of growing actin filaments (Pasic et al., 
2008). 
 
Figure 4. Mechanism of anti capping 
by Ena/VASP proteins. 
(A) Tetramer of VASP in association 
with a bundle of actin filaments. 
Interactions between the EVH1 domain 
of Ena/VASP and FPPPP-motif-
containing proteins help to position the 
Ena/VASP tetramer near the plasma 
membrane. (B) The profilin–G-actin 
loading mechanism by which 
Ena/VASP is thought to supply actin 
monomers to the barbed ends of 
filaments while antagonizing the ability 
of capping proteins to terminate 
filament elongation. Adapted from Bear 
& Gertler, J Cell Sci. 2009 Jun 
1;122(Pt 11):1882-94. 
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Cellular functions of Ena/VASP proteins 
 
The role of Ena/VASP proteins in cell migration was first studied in mouse 
embryonic fibroblasts derived from the mouse double knock-out for Mena and 
VASP and selected for low expression of EVL. When this cell line (MVD7) is 
rescued with a physiological level of Mena, EVL or VASP, the cells moved more 
slowly than the parental null line. Conversely, the overexpression of Ena/VASP 
proteins in normal fibroblasts led to slower movement (Bear et al., 2000). Rescues 
experiments, using deletion mutants of Mena, have shown the structural 
requirements for the fibroblasts motility (Loureiro et al., 2002). Re-expression of 
a mutant lacking the proline-rich region slowed cells down to the same extent as 
the wild-type protein, indicating that profilin and other ligand recruitment 
mediated by this region are dispensable for random cell migration. However, the 
proline-rich region is required for other Ena/VASP-dependent processes. The F-
actin-binding site is essential for proper fibroblast motility and for the ability of 
Ena/VASP proteins to be recruited effectively to the leading edge. An alternate 
approach to block Ena/VASP function is to remove the proteins from their normal 
localization within cells. To sequester Ena/VASP proteins on the surface of 
mitochondria, Frank Gertler group engineered the FPPPP repeats from ActA 
protein in a plasmid bearing four copies of FPPPP linked to a mitochondrial 
anchoring sequence. FPPPP-Mito blocks the function of all Ena/VASP family 
members by deleting them from their normal sites of function and replicates the 
phenotypes observed in Ena/VASP deficient cells (Bear et al., 2000). These 
observations using the null cells and re-localization strategies led to the 
conclusion that Ena/VASP proteins negatively regulate fibroblast migration 
speed. Despite the localization in focal adhesions, when Ena/VASP proteins are 
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selectively de-localized from focal adhesions, but not from the leading edge, using 
FPPPP-Cyto, random fibroblast migration speed on a fibronectin substrate is not 
affected, indicating that Ena/VASP proteins do not have a critical function in 
focal adhesions in this type of migration assay. At a gross level, the composition, 
number, and morphology of focal adhesions is unaffected by loss of Ena/VASP. 
At present, the function of Ena/VASP proteins within focal adhesions is unclear. 
A siRNA screening in MCF10A cells for genes that regulates epithelial cell 
migration show no phenotype when VASP is knock-down and an accelerated 
phenotype when Mena is knock-down, even if with 50% consistency among 
different siRNA and different experiments (Simpson et al., 2008). Another group, 
using a siRNA approach to knock-down genes important for focal adhesions 
formations and adhesions and quantitative microscopy, shows a slight changes in 
focal adhesion morphology and an increase in cell elongation when Mena is 
knock-down in HeLa cells (Winograd-Katz et al., 2009). However, both studies 
don’t look at complete knock-down of Ena/VASP family members, so no 
definitive conclusions on the role of Ena/VASP in epithelial cell lines and focal 
adhesions formation can be made 
The function of Ena/VASP proteins as negative regulators of fibroblast 
motility seemed paradoxical given that lamellipodial protrusion rate positively 
correlates with the intensity of GFP-VASP at the leading edge (Rottner et al., 
1999). A careful examination of the dynamics of lamellipodia lacking Ena/VASP 
proteins resolved this apparent conflict and indicated that such lamellipodia 
protrude more slowly, but the protrusion persists longer. Conversely, cells 
overexpressing Ena/VASP proteins have lamellipodia that protrude faster than 
controls, but these protrusions are rapidly withdrawn in the form of ruffles. 
Therefore, Ena/VASP proteins increase lamellipodial protrusion velocity but have 
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a global negative effect on cell motility. These observations have led to a more 
general conclusion that whole-cell motility rates correlate better with persistence 
of protrusion than with instantaneous protrusion rate (Bear et al., 2002). 
Interestingly, deletion or re-localization of Ena/VASP proteins from the leading 
edge causes reorganization of actin filament architecture in lamellipodia. 
Lamellipodia lacking Ena/VASP function contain actin filament networks with 
shorter and more highly branched actin filaments. Excess Ena/VASP leads to 
longer but less-branched filaments. These changes in actin network geometry are 
responsible for the changes in lamellipodial behavior and, ultimately, changes in 
cell migration rate (Bear et al., 2002). It needs to be taken into account that the 
output of Mena activity is cell type specific and can be affected by the other 
components of the protrusion machinery.  
VASP was the first molecule identified to bind ActA protein of the 
intracellular bacterium Listeria monocytogenes and this was also the first 
indication that Ena/VASP might directly regulate actin dynamics (Chakraborty et 
al., 1995; Pistor et al., 1995). Listeria is a master of mimicry that uses the host cell 
actin system both to move within the cytoplasm of infected cells and for cell-to-
cell spread. ActA binds directly to Ena/VASP through the FPPPP repeats, 
moreover the same protein binds Arp 2/3 and G-actin. Ena/VASP binds directly to 
profilin, suggesting that the recruitment of profilin by Ena/VASP proteins may be 
one function of this protein family important for Listeria motility. Listeria speed 
is reduced after depletion experiments of either Ena/VASP proteins or profilin 
from cell extracts and by the restoration of Listeria movement in both rescue 
experiments and from reconstitution of pure proteins (Laurent et al., 1999; Theriot 
et al., 1994). Ena/VASP proteins also facilitate ActA-induced Arp2/3-mediated 
actin nucleation, possibly by increasing the amount of actin monomer available on 
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the bacterial surface. Finally, Ena/VASP proteins decrease the number of F-actin 
branches induced by ActA and the Arp2/3 complex in vitro, suggesting that they 
might regulate the geometry of the actin filament network in the tails of motile 
bacteria (Skoble et al., 2000). Within living cells, Listeria speeds are reduced an 
order of magnitude in the absence of Ena/VASP proteins. Expression of 
Ena/VASP deletion mutants lacking either profilin or the G-actin-binding site in 
Ena/VASP null cells provided only a modest increase in bacterial speed relative to 
wild-type protein, indicating that both domains are important for Listeria motility. 
In contrast, deletion of the F-actin-binding site increased the Listeria speed to 
higher than wild-type levels, whereas deletion of the coiled-coil domain had no 
effect (Geese et al., 2002).  
Ena/VASP proteins co-localize with the hematopoietic-specific adaptor 
protein Fyb/SLAP; the adaptor molecules SLP-76, Nck, Vav, WASP; and the F-
actin nucleator Arp2/3 complex in phagocytic cups of macrophages. They also co-
localize at the interface between T cells and anti-CD3 coated beads (Coppolino et 
al., 2001; Krause et al., 2000). This localization of Ena/VASP is mediated by 
direct binding of the EVH1 domain to Fyb/SLAP. Ena/VASP proteins are also 
detected in a protein complex with Fyb/SLAP, SLP-76, Nck, Vav, and the Arp2/3 
activator WASP upon ligation of the T cell receptor or the Fcγ receptor of 
macrophages, indicating that two key modulators of the actin dynamics, 
Ena/VASP and WASP, can be linked in regulated, physiological processes. 
Importantly, properly localized Ena/VASP proteins and Arp2/3 are each required 
for effective Jurkat T cell polarization and for phagocytosis suggesting that 
Ena/VASP-WASP-Arp2/3 networks may function together to promote these 
processes (Coppolino et al., 2001; Krause et al., 2000; May et al., 2000).  
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Role in Neuronal Migration and Axon Guidance 
 
One of the most important and studied role of Ena/VASP regards neuronal 
migration and axon guidance. The development of the nervous system involves 
extensive migration of neurons. One of the first study of the role of Ena/VASP 
proteins in neuronal migration was performed using the FPPPP-Mito approach to 
block Ena/VASP function in cortical neurons (Goh et al., 2002). Neutralization of 
Ena/VASP function within neurons that normally migrate radially from their 
birthplace to the deep layers of the cortex resulted in frequent misplacement of 
these neurons to more superficial layers. Analysis of early stages of neuronal 
migration indicated that neurons expressing the FPPPP-Mito construct were 
already present in more superficial structures and therefore moved farther than 
control cells. During development the growth cones, the motile tips of growing 
processes, must traverse great distances and continually integrate a plethora of 
extracellular guidance signals into appropriate changes in cytoskeletal dynamics 
for proper movement. There are several reasons to believe that Ena/VASP 
proteins play important roles in intracellular signaling cascades that transduce 
extracellular guidance signals into actin dynamics within growth cone filopodia 
and lamellipodia. First, Ena/VASP proteins are concentrated at the tips of growth 
cone filopodia and lamellipodia in primary cultured neurons (Lanier et al., 1999). 
Second, all three vertebrate family members are regulated by protein kinase A 
(PKA), and at least VASP is known to be phosphorylated by protein kinase G 
(PKG) (Aszodi et al., 1999), two important kinases that modulate signaling 
downstream of many axon guidance molecules. Third, genetic studies in worms 
and flies implicate their Ena/VASP homologs in response to specific axonal 
guidance signals. In worms, unc-34 is required for proper response to netrin, a 
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guidance factor that can act either as an attractant or a repellent depending on the 
receptor repertoire and signaling context present within responding neurons 
(Colavita and Culotti, 1998; Gitai et al., 2003). In both flies and worms, 
Ena/VASP appears to function downstream of the repulsive guidance receptor 
Robo/Sax3, a molecule that binds directly to Ena/VASP through an EVH1-
binding site found on its cytoplasmic tail (Bashaw et al., 2000). In mice, deletion 
of Mena caused axonal guidance defects in the formation of the corpus callosum, 
hippocampal commissure, and pontocerebellar fiber bundles (Lanier et al., 1999). 
However, the presence of the other two members of the family with similar 
functions and overlapping expression patterns in the neocortex precluded 
complete analysis of Ena/VASP function during cortical development. To 
overcome this, Frank Gertler lab engineered a transgenic mouse triple null for 
Mena, VASP and EVL (MVE). They show that loss of Ena/VASP causes two 
defects in neuronal migration during corticogenesis: a defect in cortical 
positioning and a non-cell-autonomous defect in pial membrane integrity that 
causes neuronal ectopias. Unexpectedly, they find that loss of Ena/VASP blocks 
axon fiber tract formation in the cortex, and they demonstrate that this defect 
results from the failure of cortical neurons to produce neurites. Of mechanistic 
note, evidences suggest that the defect in neurite formation results from the 
inability of Ena/VASP-deficient neurons to make filopodia and the neurite 
formation can be uncoupled from neuronal migration (Kwiatkowski et al., 2007). 
The majority of MVE embryos were exencephalic and with a cobblestone cortex. 
Interestingly, if Ena/VASP-deficient neurons are plated on laminin, or are 
transfected with MyosinX or mDia2, a rescue of the phenotype and filopodia 
formation is observed, suggesting different extrinsic and intrinsic pathways of 
filopodia formation and neuritogenesis (Dent et al., 2007). 
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Role in endothelia and epithelia 
 
Endothelial cells line blood vessels and provide both a barrier function 
between blood and other tissue while still allowing immune cells access to the 
surrounding tissue. Barrier function requires cell-cell interactions, mediated in 
large part by adherens and tight junctions, which act to restrict the passage of 
material between cells in the endothelial lining. Both adherens and tight junctions 
use transmembrane proteins that interact with homotypic receptors on neighboring 
cells. Ligation of these receptors stimulates the cytoplasmic recruitment of 
multiprotein complexes that are involved in signal transduction and interaction 
with the cytoskeleton. The generation of the MVE mouse gave insights in the role 
of Ena/VASP in the endothelial barrier function. MVE mice exhibit edema and 
the vessel pattern and integrity are very compromised in these mice. This 
phenotype correlates in HUVEC cells, transfected with the FPPPP-mito construct, 
with an unperturbated assembly of cell-cell junctions but a reduced actin 
incorporation in the barbed end (Furman et al., 2007). Similarly to endothelial 
cells, epithelial cells form a physical boundary capable of regulating the transfer 
of molecules across the epithelial sheet. In these systems Ena/VASP proteins 
localize to adherens junctions, and disruption of their function affects epithelial 
dynamics (Grevengoed et al., 2001; Lawrence et al., 2002). Studies in Drosophila 
have demonstrated that reduction of either D-Abl or Ena affects epithelial 
morphology and epithelial sheet migration. Genetic interactions suggest that Ena 
functions in concert with components of the cadherin-catenin complex and D-Abl 
in epithelial sheets at the adherens junctions (Grevengoed et al., 2001). A more 
recent report shows that in flies Ena modulates filopodial number and length, thus 
influencing the speed of epithelial zippering and the ability of cells to match with 
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correct neighbors during dorsal closure (Gates et al., 2007). In mammals, 
Ena/VASP proteins are found in epithelial contacts that are revealed as a double 
row of dot-like structures also containing F-actin, E-cadherin, zyxin, and vinculin. 
These cell-cell contacts have been suggested to represent an early stage in 
junctions formation and have been termed the adhesion zipper (Vasioukhin et al., 
2000). In this paper the authors adopt as strategy an overexpression a fragment of 
Ena/VASP responsible for oligomerization to disrupt epithelial sheet formation. 
However, the specificity of this approach for Ena/VASP proteins has not been 
demonstrated.  
 
Molecular functions of Ena/VASP proteins 
 
Several different molecular mechanisms as been proposed to explain the 
Ena/VASP dependent phenotypes in fibroblast migration, Listeria motility and the 
others actin-dependent phenotypes underlying fisiological processes in mice. The 
first model suggested a role in de novo nucleation of actin filaments. Purified 
Ena/VASP proteins can shorten the lag phase of actin polymerization in in vitro 
assays (Bachmann et al., 1999; Huttelmaier et al., 1999; Lambrechts et al., 2000). 
However, these investigators used low salt conditions (non fisiological) to 
polymerize actin, and moreover no convincing evidence supports this mechanism 
as a physiological for Ena/VASP function in vivo, since no F-actin is recruited 
when Ena/VASP proteins were relocalized to mitochondria in intact cells (Bear et 
al., 2000). Furthermore, Listeria that exhibit defective Arp2/3 activation but still 
recruit normal levels of Ena/VASP proteins fail to assemble or recruit any 
detectable F-actin (Skoble et al., 2000). More recent experiments both in vivo and 
in vitro point to three likely molecular mechanisms of Ena/VASP function: anti 
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capping, anti-branching, and profilin recruitment. These three different 
mechanisms may work together in order to give the final output of Ena/VASP 
function, the F-actin filament growth. 
Ena/VASP proteins act to prevent or delay capping of barbed ends of actin 
filaments by capping proteins, CapZ and gelsolin, the three major barbed-end 
cappers in cells. Multiple lines of evidence support this anti capping mechanism. 
Ena/VASP proteins are localized to the leading edge of lamellipodia and the tips 
of filopodia. These locations contain a high density of actin filament barbed ends, 
and Ena/VASP localization to these places can be displaced by treatment with low 
concentrations of cytochalasin D (CD), a drug that binds with high affinity to the 
barbed ends of actin filaments and presumably displaces Ena/VASP proteins by 
competition. This observation is supported by in vitro assays in which Ena/VASP-
coated beads can capture uncapped, but not capped, actin filaments (Bear et al., 
2000). In addition, purified VASP antagonizes the activity of capping proteins and 
gelsolin in actin filament elongation assays (Barzik et al., 2005). Perhaps the most 
compelling evidence for this model comes from studies of fibroblasts with 
modified Ena/VASP function. Depletion of Ena/VASP leads to shorter actin 
filaments at the leading edge relative to controls. Conversely, overexpression of 
Ena/VASP leads to longer filaments than control cells at the leading edge (Bear et 
al., 2000). These data suggest a mechanism in which Ena/VASP proteins 
associate with actin filaments at or near their barbed ends to prevent capping by 
capping proteins. This model is supported by experiments in vivo in which low 
doses of CD were used to reverse Ena/VASP-dependent motility phenotypes in 
fibroblasts. This CD treatment mimics capping proteins overexpression and 
reduced the filament length to wild-type levels, indicating that a balance between 
capping proteins levels and Ena/VASP activity regulates actin filament geometry 
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in lamellipodia (Bear et al., 2002). Recent findings reinforce the anti capping 
activity of Ena/VASP. Using Total Internal Reflection Fluorescence Microscopy 
(TIRF) and VASP immobilized on a coverslip, Dorothy Schafer lab has shown 
that purified VASP delayed termination of filament growth by heterodimeric 
capping protein. The filament elongation rate was enhanced by addition of 
profilin along with VASP (Pasic et al., 2008). The Jan Faix group has also shown 
anti capping activity of VASP. In these studies, VASP immobilized on beads was 
capable of supporting continuous elongation of filaments even in the presence of a 
very high concentration of capping proteins (Breitsprecher et al., 2008). This 
study did not find anti capping activity for VASP when it was in solution, as 
others have; however, this may be due to differences in specific assay conditions 
or protein preparation or storage conditions.  
Several groups have noted that Ena/VASP proteins reduce the frequency of 
actin-filament branching by the Arp2/3 complex (Bear et al., 2002; Samarin et al., 
2003; Skoble et al., 2000). Skoble and colleagues observed that VASP reduced 
the branching induced by ActA-activated Arp2/3 complex in visual assays. These 
reactions did not contain capping proteins and the observed anti-branching 
activity must be independent of its anticapping function. Nothing more is know 
about the mechanisms of anti-branching mediated by Ena/VASP. 
Recent structural and biochemical analyses indicate that VASP harbors a 
high-affinity profilin-binding “actin-loading site” adjacent to its actin-monomer-
binding motif (Chereau and Dominguez, 2006; Ferron et al., 2007). The structural 
studies suggest a model in which profilin-G-actin binds to the Ena/VASP loading 
site in a manner that allows the actin monomer to bind to the Ena/VASP G-actin 
binding site (which is adjacent to the F-actin-binding motif). Such a model would 
explain how actin monomers could be transferred efficiently from profilin to the 
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barbed ends of actin filaments while bound to Ena/VASP; the model is consistent 
with the ability of profilin to increase Ena/VASP anti capping activity by 
increasing filament-elongation rates, however, profilin is not required for VASP 
anti capping activity in vitro (Barzik et al., 2005). Profilin recruitment by 
Ena/VASP plays an important role in supporting Listeria motility within living 
cells. EGFP-Profilin co-localizes only with moving Listeria, and its intensity 
correlates positively with the speed of the bacteria and Ena/VASP deficient cells 
that are complemented with forms of Mena or VASP that cannot bind profilin (the 
proline-rich deletion) do not support Listeria movement as effectively as wild-
type protein (Geese et al., 2002).  
 
Regulation of Ena/VASP proteins 
 
The mammalian Ena/VASP proteins are known substrates of cAMP and 
cGMP- dependent serine and threonine kinases PKA and PKG (Gertler et al., 
1996; Lambrechts et al., 2000). VASP harbors three phosphorylation sites (Ser-
157, Ser-239, and Thr-278), whereas Mena contains the first two, and EVL only 
the first site (Butt et al., 1994; Gertler et al., 1996; Lambrechts et al., 2000). 
Studies of mutant mice revealed that VASP is required for the PKA-mediated 
inhibition of platelet aggregation (Aszodi et al., 1999) suggesting that VASP is 
the critical PKA substrate required for this process, and that Ser-157 may be the 
key site of regulation. In random fibroblast migration, phosphorylation of Mena at 
its first phosphorylation site (S-236, the equivalent of VASP Ser-157) is essential 
for its function. A non-phosphorylatable S-236-A Mena mutant localizes normally 
when expressed in Ena/VASP-deficient cells, yet fails to rescue the hypermotile 
phenotype of Ena/VASP null cells (Loureiro et al., 2002). Conversely, a 
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phosphomimetic S-236-D Mena mutant complements the fibroblast phenotype. 
Therefore, it seems likely that phosphorylation is not essential for Ena/VASP 
subcellular targeting but is probably required to regulate Ena/VASP function in 
lamellipodia. Phosphorylation of wild-type VASP (in particular S235) by PKA in 
vitro abolished VASP anti capping activity in the presence and absence of profilin 
and bundling formation (Barzik et al., 2005), probably because of an negative 
charge over phosphates that can interfere with F-actin binding. Ena/VASP can be 
phosphorylated in tyrosine as well. In fact, Enabled was identified as target of Abl 
kinase in Drosophila (Gertler et al., 1995). However, at present it is unclear 
whether tyrosine phosphorylation of Ena is important for its function.  
 
Ena/VASP alternative splicing and splicing regulation 
 
Human and mouse Mena contain at least 4 published isoforms (Figure 5) 
and other isoforms currently under investigation in the Frank Gertler and the 
Paola Nisticò laboratories. The larger isoform of Mena, called +, contains an extra 
246 additional amino acids after the LERER repeats (Gertler et al., 1996), and is 
express in developing and adult brain tissues (Lanier et al., 1999). The + exon is 
proline rich and can be tyrosine phosphorylated in vivo (Gertler et al., 1996). 
Some cDNA containing the + exon may also contain two other small exons that 
introduce 4 and 19 aminoacids, right after the EVH1 domain, called ++ or +++ 
(INV) (Gertler et al., 1996). The EVH2 of Mena can contain a 21 aminoacids 
insertion between the F-actin and the coiled-coil domain. This isoform is called 
Mena11a, is expressed in epithelial tissues (Di Modugno et al., 2007; Pino et al., 
2008; Balsamo et al., manuscript in preparation) and is the main focus of this 
thesis. Another isoform of Mena, identified by Tani and colleagues, is mainly 
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express in the spleen and in lymphoid cell lines. This isoform, called MenaS 
(short) lacks the aminoacids 300-333 in mouse Mena (Tani et al., 2003), so it 
should be incapable of binding profilin. Russ Carstens group identified two splice 
factor proteins ESRP1 and ESRP2 as regulators of the epithelial splicing. Among 
several other genes analyzed, the splicing of Mena11a seems to be regulated by 
these two splicing factors (Warzecha et al., 2009a; Warzecha et al., 2009b). 
 
 
 
 
 
 
 
EVL is expressed in two isoforms, the larger one is called EVL-I and 
similarly to Mena11a, has a 21 aminoacids insertion right before the 
tetramerization domain (Lambrechts et al., 2000). We have shown that EVL-I can 
be phosphorylated by Protein Kinase D and like Mena11a, is also enriched in 
basal keratinocytes in mouse skin (Janssens et al., 2009).  
 
Ena/VASP in cancer 
 
The first indication of a role for Mena in cancer came from Paola Nisticò’s 
group. With the goal of identifying new tumor-associated antigens in breast 
cancer, the screening of a cDNA library from a primary breast tumor with the 
autologous patient serum led to the isolation of a cDNA that encoded the Mena 
gene. The majority of the human sera screened showed anti Mena specific IgG 
and further analyses have shown overexpression of Mena in cancer cell lines and 
Figure 5. Mena isoforms scheme. 
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in breast cancer patients (Di Modugno et al., 2004). The same year, two other 
reports showed that Mena mRNA was upregulated in invasive and metastatic 
cells. John Condeelis laboratory found that Mena is part of the “minimum motility 
machinery” genes that are upregulated in the subpopulation of mammary cancer 
cells chemoactratted by Epidermal Growth Factor (EGF) in vivo, compared to the 
primary tumor cells (Wang et al., 2004). Robert Weinberg’s group found Mena 
upregulated in metastatic cells that also upregulated the transcription factor Twist 
(Yang et al., 2004). 
A better characterization of Mena overexpression in human breast cancer 
patients was published in 2006 by Di Modugno et al. Mena was progressively 
overexpressed during breast cancer progression and this overexpression correlated 
with the proliferation index, the downregulation of Estrogen Receptor (ER) and 
Progesteron Receptor  (PgR) and upregulation of Human Epidermal Growth 
Factor Receptor 2 (HER-2) (Di Modugno et al., 2006). The same group did 
further characterization of Mena function in cancer. We cloned and characterized 
Mena coding sequence and identified Mena11a, an alternative splicing isoform. 
We showed that Mena overexpression characterizes the transformed phenotypes 
and that treatment of breast cancer cells with EGF further upregulates Mena 
expression. The importance of this finding is due to the fact that EGF has a central 
role in the mammary gland biology and breast cancer progression.  Interestingly, a 
shift versus more acidic pH (and a reversion of the shift in samples treated with 
phosphatase) of Mena11a was observed in protein extracts of EGF-treated cell 
lines. The overexpression of Mena11a was associated with an increase in cell 
proliferation and phosphorylation of Mitogen Associated Protein Kinase (MAPK) 
(Di Modugno et al., 2007). The functional role of Mena overexpression by EGF, 
the role of the putative Mena11a phosphorylation and the modulation of breast 
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cancer cells proliferation by Mena11a are still open questions that need to be 
further addressed and explored.  
To extend our findings to other epithelial cancers, we looked into the role of 
Mena isoforms in human ductal pancreatic cancer cells. Interestingly, we found 
that Mena11a is expressed in pancreatic cancer cell lines with an epithelial 
phenotype, while downregulated in cells that express mesenchymal markers, 
addressing for the first time a role for Mena11a during the Epithelial to 
Mesenchymal Transition (EMT) (Pino et al., 2008). Of great interest for 
pancreatic cancer, we found that Mena11a may serve as a marker of sensitivity for 
EGFR targeted therapy since its expression is able to distinguish between 
Erlotinib (an EGFR tyrosine kinase inhibitor) sensitive versus resistant cell lines. 
We have also shown for the first time Mena expression in human pancreatic 
cancer tissues and metastasis (Pino et al., 2008).  
Mena has also been shown to be overexpressed in colorectal cancer (Gurzu 
et al., 2008; Toyoda et al., 2009) and cervical cancer (Gurzu et al., 2009) lesions, 
even though these studies are performed on a very small number of patients. 
A step forward for the understanding of the contribution of Mena in cancer 
came from Frank Gertler laboratory. The authors have found that Mena, and a 
splice isoform in particular (MenaINV/+++) plays a major role during mammary 
cancer invasion and metastasis (Philippar et al., 2008). MenaINV localizes to the 
leading edge of motile carcinoma cells in vivo and its overexpression promotes 
metastasis dissemination in the lungs. MenaINV promotes 3D invasion and matrix 
degradation in vitro, acting on stabilization of invadopodia, actin-rich structures 
that are need to invade 3D matrices. Interestingly, MenaINV overexpressing cells 
respond to low concentration of EGF, forming lamellipodia with an area bigger 
than control cells. This is associated with a promotion of actin incorporation at the 
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barbed ends in a cofilin-dependent manner (Philippar et al., 2008). The molecular 
mechanisms of the MenaINV-dependent EGF sensitivity in mammary cancer cells 
is still unclear. 
EVL gene seems to be methylated in colorectal carcinomas (Grady et al., 
2008) while upregulated in breast cancer patients, and this correlates with clinical 
stages (Hu et al., 2008). We have shown that EVL and EVL-I are highly 
expressed in breast cancer cell lines an in a B-cell lymphoma cell line as well 
(Janssens et al., 2009). Of note, in MCF7 human breast cancer cells, EVL 
unexpectedly binds to the RAD51 and RAD51B proteins, central players in 
homologous DNA recombination repair and stimulates the RAD51-mediated 
homologous pairing and strand exchange, adding a new role to this molecule 
(Takaku et al., 2009a). Moreover the same group also found that the DNA-
binding activity of EVL resides in the EVH2 (Takaku et al., 2009b). The 
contribution of VASP in cancer is still unknown.  
 
Epithelial to Mesenchymal Transition  
 
The Epithelial to Mesenchymal Transition (EMT) is a biological process 
that allows a polarized epithelial cell, which normally interacts with a basement 
membrane via its basal surface, to undergo multiple biochemical and 
morphological changes that enable it to assume a fibroblastic-like, mesenchymal 
phenotype, which includes enhanced migratory capacity, invasiveness, elevated 
resistance to apoptosis and greatly increased of extracellular matrix (ECM) 
compounds. The completion of an EMT is signaled by degradation of ECM by a 
mesenchymal cell that migrates away from epithelial layer in which it originated 
(Thiery and Sleeman, 2006). The EMT program is activated at multiple steps of 
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embryonic development to enable the conversion of various types of epithelial 
cells into mesenchymal cells. Passage through an EMT, however, does not 
necessarily represent an irreversible commitment to switch differentiation 
lineages. Thus, the reverse program, termed the Mesenchymal to Epithelial 
Transition (MET), also occurs both during embryonic development and during 
several pathological processes. The reversibility of this process underscores the 
enormous plasticity of certain embryonic and adult cells that participate in 
processes of disease pathogenesis. Since EMTs are encountered in three distinct 
biological context that carry different functional consequences, a recent 
classification of the EMT processes has been proposed (Kalluri and Weinberg, 
2009). Type I EMT is associated with implantation (Vicovac and Aplin, 1996), 
embryo formation, and organ development, such as cardiac valve formation 
(Bolender and Markwald, 1979) and secondary palate formation (Fitchett and 
Hay, 1989). These type I EMTs are the implantation of the embryo and the 
initiation of placenta formation (Vicovac and Aplin, 1996), cardiac valve 
formation (Bolender and Markwald, 1979) and secondary palate formation 
(Fitchett and Hay, 1989). Type II ETMs are associated with tissue regeneration 
and organ fibrosis. Inflammatory cells and fibroblasts that release inflammatory 
signals and ECM often mediate fibrosis. EMT has been found to be associated 
with fibrosis of kidney, liver, lung, heart and intestine (Kim et al., 2006; Zeisberg 
et al., 2007a; Zeisberg et al., 2007b). Type III EMT is associated with cancer 
progression and metastasis. The genetic control and biochemical mechanisms 
underlying the acquisition of an invasive phenotype and the subsequent systemic 
spread of cancer cell have been extensively studied areas and in many studies, the 
activation of an EMT program has been proposed to be the underlying 
mechanisms for the acquisition of malignant phenotypes by epithelial cancer cells 
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(Thiery, 2002). The full spectrum of signaling agents that contribute to EMTs of 
carcinoma cells remains unclear. One suggestion is that the genetic and epigenetic 
alterations undergone by cancer cells during the course of primary tumor 
formation render them especially responsive to EMT-inducing heterotypic signals 
originating in the tumor-associated stroma. Oncogenes induce senescence, and 
recent studies suggest that EMT may also play a role in preventing senescence 
induced by oncogenes, thereby facilitating subsequent aggressive dissemination 
(Ansieau et al., 2008). In the case of many carcinomas, EMT-inducing signals 
emanating from the tumor-associated stroma, notably HGF, EGF, PDGF, and 
TGF- ß, appear to be responsible for the induction or functional activation in 
cancer cells of a series of EMT-inducing transcription factors (Joyce and Raghu, 
2007). The actual implementation by these cells of their EMT program depends 
on a series of intracellular signaling networks involving, among other signal-
transducing proteins, ERK, MAPK, PI3K, Akt, Smads, RhoB, ß-catenin, 
lymphoid enhancer binding factor (LEF), Ras, and c-Fos as well as cell surface 
proteins such as α4 integrins, α5ß1 integrin, and αVß6 integrin. Activation of 
EMT programs is also facilitated by the disruption of cell-cell adherens junctions 
and the cell-ECM adhesions mediated by integrins. TGF-ß is an important 
suppressor of epithelial cell proliferation and thus primary tumorigenesis. 
However, it is now clear that in certain contexts it can also serve as a positive 
regulator of tumor progression and metastasis (Massague, 2008). Thus, in vitro 
studies have demonstrated that TGF-ß can induce an EMT in certain types of 
cancer cells (Vincent et al., 2009). Some data indicate that p38 MAPK and RhoA 
mediate an autocrine TGF-ß–induced EMT in NuMG mouse mammary epithelial 
cells (Bhowmick et al., 2001). TGF-ß can induce an EMT in Ras-transformed 
hepatocytes, mammary epithelial cells (via MAPK), and MDCK cells; at the same 
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time, Ras-activated PI3K inhibits TGF-ß–induced apoptosis to facilitate this 
transition (Janda et al., 2002). Typical hallmarks of EMT in cancer are the 
changes of differentiation markers from cell-cell junction proteins and cytokeratin 
intermediates filaments to vimentin filaments and fαibronectin. E-cadherin loss 
has been associated with carcinoma progression and poor prognosis in various 
epithelial cancers (Vincent-Salomon and Thiery, 2003). The best demonstration of 
this process is familiar gastric cancers in which the E-cadherin germline mutations 
play a causal role (Guilford et al., 1998). Activation of tyrosine kinase receptors 
in tumor cells can lead to disruptions of cell-cell junctions, with degradation of E-
cadherin and ß-catenin (Fujita et al., 2002). In the majority of human carcinoma 
cell populations, the loss of E-cadherin appears to be heterogeneous, with foci of 
E-cadherin-positive carcinoma cells scattered among E-cadherin-negative areas. 
Moreover, E-cadherin is often detected in distant metastases, which may derive 
from cells that have previously passed through an EMT (Bukholm et al., 2000; 
Bukholm et al., 1998). This suggests that after their initial dissemination, some 
metastatic cells may revert to an epithelial state, and it indicates that other, non 
genetic mechanisms controlling transcription of the E-cadherin gene or post-
translational modification of the E-cadherin protein may be responsible for the 
lack of expression of this protein in some tumor cells. Indeed, many EMT-
inducing transcription factors, including Snail, Slug, EF1, SIP1, Twist1, FOXC2, 
ZEB1-2 and Goosecoid, have been associated with tumor invasion and metastasis. 
Expression of almost all of these genes has been detected in certain invasive 
human and mouse tumor cell lines. Expression of Twist-1 has been shown to be 
essential for a mouse breast carcinoma cell line to metastasize from the mammary  
gland to the lung (Yang et al., 2004) and overexpression of FOXC2 or Goosecoid 
increases the ability of weakly metastatic human carcinoma cells to disseminate 
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(Hartwell et al., 2006; Mani et al., 2007). Mina Bissell laboratory has reported 
that matrix-degrading enzymes such as MMP-3 facilitate EMT by inducing 
genomic instability via Rac1b and ROS (Radisky et al., 2005). Noncoding 
microRNAs are also components of the cellular signaling circuitry that regulates 
the EMT program. For example, microRNA 200 (miR200) and miR205 inhibit 
the repressors of E-cadherin expression, ZEB1 and ZEB2, and thereby help in 
maintaining the epithelial cell phenotype (Gregory et al., 2008; Korpal et al., 
2008). In breast carcinoma, a loss of miR200 correlates with increased expression 
of vimentin and a decrease in the levels of E-cadherin in cancer cells. Acting in 
the opposite direction, miR21 is upregulated in many cancers and facilitates TGF-
ß induced EMT (Zavadil et al., 2007). Interestingly, CD44hi/CD20lo cells purified 
from normal and malignant breast cancer tissue exhibit features of an EMT, and 
human cancer cells induced to undergo EMT exhibit stem cell-like properties and 
increased metastatic potential (Mani et al., 2008). One major difficulty in 
demonstrating the role of EMT in metastasis in human cancers is identifying 
carcinoma cells that have passed through an EMT in primary human tumor 
samples. Most of the EMT markers currently used are expressed in either 
epithelial or mesenchymal cells, and therefore are not specific for identifying 
tumor cells at the EMT stage that are scattered among the many stromal cells 
present within a primary tumor. A few studies have shed some light on the 
existence of such EMT carcinoma cells in primary human cancers. The EMT-
inducing transcription factor Twist-1 is overexpressed in two human cancer types, 
lobular breast carcinoma and diffused-type gastric cancer. Over 90% of these 
tumors do not express E-cadherin and exhibit a permanent EMT phenotype (Yang 
et al., 2004). In colorectal cancers that contain APC or ß-catenin mutations, ß-
catenin expression is predominantly observed in tumor cells localized at the 
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invasion front and scattered in the adjacent stromal compartment. More 
interestingly, tumor cells with nuclear ß-catenin accumulation appear to have 
undergone an EMT, as demonstrated by the progressive loss of E-cadherin 
expression and acquisition of mesenchymal markers such as fibronectin (Fodde 
and Brabletz, 2007). Despite these various observations, the involvement of EMT 
in human cancer metastasis is still highly debated, due in part to clinical 
observations showing that the majority of human breast carcinoma metastases 
express E-cadherin and maintain their epithelial morphology, suggesting that they 
have disseminated without switching to a mesenchymal phenotype (Tarin et al., 
2005). Several studies in mouse tumor models have also suggested that tumor 
invasion and metastasis can be achieved without an obvious EMT phenotype. In a 
TGF- ß1-induced mouse skin tumor model, blocking the EMT program with a 
dominant-negative TGF- ß type 1 receptor did not inhibit the occurrence of distant 
metastases (Han et al., 2005). Collective cell invasion (Wicki et al., 2006) and 
fibroblast-led collective invasion (Gaggioli et al., 2007) have also been 
responsible for carcinoma cell local invasion into the extracellular space. Indeed, 
cell migration during several developmental events does not require a complete 
EMT phenotype. However, partial EMT and collective cell migration are not 
sufficient to explain how individual tumor cells can intravasate into the blood 
circulation and travel to distant organs. Some of these controversies are due to the 
depiction of EMT as a permanent, irreversible process occurring during the course 
of tumor metastasis. Indeed, a reversible EMT model has been proposed to 
describe the transient activation of the EMT program that carcinoma cells undergo 
during tumor metastasis (Thiery, 2002). In this model, carcinoma cells activate 
the EMT program to achieve local invasion and dissemination to distant organs. 
Once they have reached those organs, these mesenchymal cells may revert via 
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MET to an epithelial identity and thereby regain proliferative ability and the 
ability to form epithelial growths in distant organ sites. Moreover, cancer cells 
may, more often than not, pass through a partial EMT program rather than a 
complete one; such cells may concomitantly express epithelial and mesenchymal 
markers. Better EMT mouse tumor models will be needed to test this hypothesis 
rigorously. 
 
The tumor microenvironment 
 
Tumors are complex ecologies of different cell types and the full 
manifestation of the malignant phenotype requires an appropriate 
microenvironment. The tumor-surrounding stroma contains a plethora of non-
cancerous cells and different bone marrow-derived cells, embedded in the ECM. 
Among the stromal cell types that have been implicated in the tumor promotion 
are endothelial cells, pericytes, fibroblasts, macrophages, neutrophils, mast cells, 
myeloid cell-derived suppressor cells, lymphocytes, NK cells and mesenchymal 
stem cell (Joyce and Pollard, 2009b). Several cross talks between cancer cells and 
stromal cells have been reported as fundamental for tumor progression and 
metastasis. For example, cancer-associated fibroblasts secrete matrix 
metalloproteinases (MMPs) that are needed to degrade extracellular matrix and 
facilitate tumor cell stromal infiltration; fibroblast secreted protein-1 (FSP-1) 
which may inactivate p53 and interact with the cytoskeleton; CXCL-12 (SDF-1), 
which stimulates proliferation and chemoattraction of carcinoma cells through 
CXCR-4 and TGF-ß, which is a known tumor-promoting growth factor in the 
later stage of carcinoma progression (Egeblad et al., 2005).  Fibroblasts are also 
responsible to secrete ECM proteins like collagens, fibronectin and laminin 
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(Kalluri and Zeisberg, 2006). The stroma is an innate anticancer mechanism, since 
it’s needed to provide substratum and polarity to epithelia. Indeed, loss of polarity 
leads to increased cell proliferation and tumorigenesis (Bissell and Radisky, 
2001). The inherent inflammation that is often associated with tumors may 
contribute to the so-called reactive stroma, a stroma with an increased number of 
fibroblasts, enhanced capillary density and type I collagen. The presence of 
leucocytes in tumors in the past was generally thought to be a consequence of a 
failed attempt at cancer cell destruction. However, tumors are not only effective in 
escaping from immune-mediated rejection, but they also modify certain 
inflammatory cell types to render them tumor promoting rather then tumor 
suppressive. For example, CD4+ T cells, macrophages and NKT cells have either 
tumor-suppressive or tumor-promoting properties, depending on the tissue context 
and cellular stimuli (de Visser et al., 2006). The presence of macrophages 
infiltration correlates with poor patient prognosis (Bingle et al., 2002). An 
interesting cross talk between mammary cancer cells and macrophages as been 
shown by John Condeelis laboratory. A paracrine loop in which Epidermal 
Growth Factor (EGF) produced by tumor associated macrophages (TAM) 
increases the invasiveness and the invasion of neighboring breast cancer cells that 
express EGF receptor has been found. Cancer cells in turn express Colony 
Stimulating Factor 1 (CSF-1), which acts as potent chemoattractant and 
chemokinetic molecule for CSF1-R expressing TAMs (Goswami et al., 2005). 
Thus, a possible “invasive niche” exists within the primary tumor, in which the 
proximity of a triad of macrophage, cancer cell and endothelial cell establishes 
paracrine signaling loops that lead to enhanced intravasation and dissemination of 
cancer cells. Indeed, clusters of these three different cell types, termed the Tumor 
Microenvironment of the Metastasis (TMEM), are found in human breast cancer 
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and their increased density is associated with the development of distant organ 
metastasis (Robinson et al., 2009). Recently, a new player in this invasive niche 
has been found to be important for the formation of pulmonary metastasis from 
mammary cancer. Lisa Coussens group, employing elegant genetic experiments, 
has shown that Th2-polarized CD4+ T lymphocytes express IL-4 and IL-13, these 
interleukins regulate TAMs to upregulate EGF mRNA and induction of mammary 
cancer cells to give raise to lung metastases (DeNardo et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Michele Balsamo PhD thesis 
 49 
Outline of the PhD thesis 
 
My PhD thesis focuses in the understanding of the mechanisms of Mena-
mediated cancer cell migration and Ena/VASP-dependent epithelial 
morphogenesis. In particular, my project aims to shed light on an alternatively 
spliced isoform of Mena, Mena11a, that we have previously isolated and 
identified in a luminal human breast cancer cell line (Di Modugno et al., 2007). 
We have indeed shown that Mena11a is exclusively expressed in human breast 
and pancreatic ductal adenocarcinoma cell lines with an epithelial phenotype 
(Pino et al., 2008). Intriguingly, in human pancreatic cancer cells Mena isoforms 
expression pattern was predictive of response to EGFR inhibition (Pino et al., 
2008).  
Based on these findings this thesis aims to evaluate whether Mena11a acts 
as a regulator of Mena activity in epithelial cells and whether Mena11a itself can 
have a specific role in epithelia. In order to investigate these hypotheses, we 
looked into the regulation of the actin cytoskeleton dynamics in vitro, in vivo, and 
in transgenic mice.  
The finding that Mena11a expression correlates with EMT markers has 
prompted us to test whether Mena11a could also be downregulated in an 
established mammary EMT model. We show that the overexpression of the 
transcription factor Twist, a master regulator of EMT (Yang et al., 2004), in 
human mammary epithelial cells (HMLER) leads to downregulation of Mena11a 
at the mRNA and protein levels. To gain further insight into the regulation of 
Mena11a splicing during EMT, we engineered HLME cells with a splice reporter 
to follow Mena11a splicing; these cells are being injected in mice and we will 
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further look at the behavior of the splice reporter cells in vivo by multiphoton 
microscopy.  
In addition, we found that Mena11a is highly expressed and co-localizes 
with Pan-Mena in the primary mammary tumors of MMTV-PyMT mouse model. 
Invasive cells collected by a 3D in vivo invasion assay, down-regulate Mena11a 
and up-regulate Mena and vimentin, a mesenchymal marker. Interestingly, 
Mena11a is re-expressed in the mammary lung metastases in this mouse model. 
We observed a more defined Mena11a staining to the cell-cell junctions of 
macrometastases compared to micrometastases, while Pan-Mena localizes to the 
junctions independently of the metastasis size, suggesting an important role for 
Mena11a in the Mesenchymal to Epithelial Transition (MET) process.  
In mammary carcinoma cells Mena11a overexpression dampens the EGF-
mediated lamellipodia protrusion. Moreover, in an in vivo 3D cell invasion model, 
Mena11a overexpression suppresses the EGF-mediated invasion of these 
carcinoma cells. Experiments looking at the contribution of barbed end formation 
and actin polymerization by Mena11a in cells are currently ongoing.  
Since the 11a insertion falls in the EVH2 domain of Mena, the domain that 
is needed to exploit the function of Mena, we asked whether and how Mena11a 
affects the cytoskeleton dynamics. We found that Mena11a retains actin binding 
and bundling activity, typical of Ena/VASP, but lacks of F-actin barbed end 
capture activity in vitro. So we can hypothesize that the sequence between the F-
actin and the tetramerization domain of Mena may be important for the initial F-
actin barbed end binding. Moreover, Mena11a doesn’t drive filopodia formation 
while Mena does, an activity highly related to the ability of binding barbed ends 
of growing actin cables in filopodia. Although the anti capping activity of 
Mena11a seems to be as potent as the one of Mena in pyrene actin assays, further 
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experiments where the population of actin filaments can be followed individually 
are required.  
We investigated the role of Ena/VASP in the junction formation in mice 
triple-knock outs for Mena, VASP and EVL (MVE). MVE mice are essential to 
understand the physiology of Ena/VASP. We have found EVL-I, an isoform of 
EVL, to be highly expressed in the skin (Janssens et al., 2009). E16.5 MVE 
embryos show an open-eye phenotype and defects in the basal layer of the 
epidermis, suggesting an important role in the epithelial sheets migration and 
junctions formation. Since the lack of Ena/VASP is embryonic lethal, we started 
to generate Mena conditional, VASP and EVL null mice (MCVE) crossed with 
mice bearing CRE recombinase under the control of skin-specific promoters. 
Analysis of the epidermis in the adults and wound healing in vivo will be 
performed in the near future. Moreover, to investigate the molecular mechanisms 
of junction formation in these mice, epidermal keratinocytes from MCVE mice 
will be used as model and the junctions assembly will be monitored in the null 
keratinocytes or in the Mena single-isoform expressing reconstituted cells. 
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 Chapter 2 - Experimental Procedures 
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Cell lines, mouse keratinocytes primary culture and tissue samples 
 
All human cancer cell lines were mantained in DMEM supplemented with 
10% Fetal Bovine Serum (Hyclone), L-glutamine, and antibiotics 
(penicillin/streptomycin; Invitrogen). MTLn3 cells were maintained in alpha-
MEM supplemented with 5% Fetal Bovine Serum (Hyclone), L-glutamine, and 
antibiotics (penicillin/streptomycin; Invitrogen). Adherent monolayer cultures 
were incubated at 37°C in a mixture of 5% CO2 and 95% air. MVD7, Ena/VASP-
deficient mouse embryonic fibroblastic cells, were isolated as described in Bear et 
al. 2000, and cultured at 32°C in Immorto medium [high-glucose Dulbecco’s 
modified Eagle’s with 15% FCS, penicillin/streptomycin, l-glutamine, and 50 
U/mL recombinant mouse IFN-γ (Invitrogen)].  
Mouse primary keratinocytes were isolated from the skin of neonatal mice. 
Skin were incubated over night at 4°C with 2 U/ml Dispase I and II solution 
(Roche). Next day, epidermis were separated from the dermis, minced and 
incubated for 10-20 minutes in 0.25% Trypsin solution (Gibco) at 37°C. 
Epidermis were passed through 45 µm cell strainers to obtain a single cell 
suspension of keratinocytes. Cells were maintained in S-MEM calcium free 
(Invitrogen), supplemented with 4% chelated FBS, 0.05 mM CaCl2, 0.4 µg/ml 
hydrocortisone (Sigma Aldrich), 5 µg/ml bovine insulin (Sigma Aldrich), 10 
ng/ml recombinant human epidermal growth factor (Invitrogen), 10-9 M cholera 
toxin (ICN), 2x10-9 M 3,3’,5-triiodo-L-thyronine (T3) (Sigma Aldrich), 
100units/ml penicillin and 100 µg/ml streptomycin, 2mM L-glutamine and 0,1 gr/l 
MgSO4. For calcium switch experiments, calcium concentration in the culture 
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media was raised to 1.8 mM. Keratinocytes were incubated at 37°C in a mixture 
of 5% CO2 and 95% air. 
Mice were sacrificed at different embryonic and adult ages, and dissected 
immediately. MMTV-PyMT mice were sacrificed at 4 months. Tissues were then 
fixed in 3.7% buffered formalin, processed and embedded in paraffin.  
 
Molecular cloning 
 
EGFP-Ena/VASP family members and Mena splice isoforms were 
subcloned into retroviral vector packaging murine stem cell virus-EGFP using 
standard techniques. Plasmids to express N-terminal His6-tagged murine EVH2 
domain proteins were constructed from PCR fragments cloned into pQE-80L 
(Qiagen). 
 
Retroviral packaging, infection and fluorescence-activated cell sorting 
 
Retroviral packaging, infection, and fluorescence-activated cell sorting were 
performed as previously described (Bear et al, 2000). Briefly, retroviral plasmids 
were transiently transfected into 293 Phoenix cells together with pCL-Eco helper 
plasmid, and supernatant was collected after 48 h. MVD7 cells were exposed to 
infectious supernatant for 24 h in the presence of 8 mg/mL polybrene (Invitrogen) 
and cultured to 90% confluence, trypsinized, and fluorescence-activated cell 
sorting sorted in PBS/5% FCS. MVD7 cells expressing EGFP-Mena isoforms were 
FACS sorted to a level of expression similar to the endogenous expression of 
Mena in mouse embryonic fibroblasts. MTLn3 EGFP-Mena cells were FACS 
sorted to as described in Philippar et al, 2008. 
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Western blotting and immunoprecipitation 
 
Cells were lysed in NP-40 buffer (1% NP-40, 150 mM NaCl, and 50 mM 
Tris, pH 8.0) containing protease inhibitors (Complete tablets; Roche) and 
phosphatase inhibitors (1 mM sodium vanadate, 50 mM sodium fluoride, 40mM 
beta-glicerophosphate, 15mM sodium pyrophosphate). Protein extracts were run 
on 8% SDS-PAGE gels, transferred on PVDF membranes (Millipore), blocked in 
5% milk in TTBS for 1h at RT and probed with the following antibodies: mouse 
monoclonal anti Mena (stock 1µg/µl; 1:5000), rabbit polyclonal anti Mena11a 
(stock 1µg/µl; 1:5000), mouse anti E-cadherin (1:2000), mouse anti N-cadherin 
(1:2000), mouse anti vimentin (1:2000), mouse anti tubulin (1:10000) (all from 
BD biosciences), mouse anti a.v.GFP (1:10000; Clontech), rabbit anti GFP 
(1:5000; BD biosciences). Mouse and rabbit affinity purified normal IgG and 
HRP secondaries (1:5000) were from Jackson Immunoresearch. PVDF 
membranes were developed with ECL reagents (GE). 
For immunoprecipitation experiments, MTLn3 cells stably overexpressing 
EGFP-Mena isoforms or EGFP were lysed in IP buffer (1% NP-40, 200 mM 
NaCl, and 50 mM Tris, pH 8.0, 10% v/v glycerol and 2mM EDTA) containing 
protease inhibitors (Complete tablets; Roche) and phosphatase inhibitors (1 mM 
sodium vanadate, 50 mM sodium fluoride, 40mM beta-glicerophosphate, 15mM 
sodium pyrophosphate). 2 mg of cell lysates were incubated with Protein A/G 
Sepharose beads (Pierce) with rotation at 4°C for 1h (preclearing). The precleared 
lysates were incubated o.n. with 2 µg of anti GFP, anti Mena11a or the normal 
IgG at 4°C on rotation. The immune complexes were immobilized on Protein A/G 
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Sepharose beads for 1h (rotation, 4°C), washed on ice cold IP buffer and boiled in 
SDS sample buffer.  
Immunofluorescence microscopy 
 
Cells were plated on glass coverslips, fixed in buffered 4% 
paraformaldehyde for 15 min at RT, permeabilized in 0.2% Triton X-100 in PBS, 
blocked in 10% BSA for 30 minutes and incubated with the following antibodies: 
mouse anti Mena (stock 1µg/µl; 1:1000), rabbit polyclonal anti Mena11a (stock 
1µg/µl; 1:1000), mouse anti E-cadherin (1:1000), mouse anti Vinculin (1:400; BD 
biosciences), mouse anti p34ARC (10 µg/ml; Upstate) for 1h at 37°C, washed 3 
times in PBS and incubated with fluorescently labeled secondary antibodies and 
Phalloidin or Hoechst (Alexa Fluor, Molecular probes), to stain F-actin or DNA, 
respectively. For tissues staining, 5 µm sections were deparaffinized in xylene, 
treated with a graded series of alcohol, rehydrated in PBS and microwaved for 15 
minutes at 96°C for antigen retrieval in 10 mM citrate buffer, pH 6.0. Sections 
were preincubated with 10% normal donkey serum in 0.5% Tween-20 for 2h at 
RT, incubated with primary antibodies in 1% donkey serum and 0.5% Tween-20 
buffer o.n at 4°C, washed 3 times in PBS and incubated in fluorescently labeled 
secondaries antibodies (Alexa Fluor, Molecular probes) for 2h at RT and Hoechst 
to label the DNA. 
Cells were imaged using a Deltavision microscope (Applied Precision, 
Olympus IX71, 60x/1.4NA Plan Apon Nikon objective), deconvolved and 
processed using Softworx software (SGI, Montain View, CA). Levels were 
adjusted with Adobe Photoshop. 
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Live cell imaging 
 
For live cell imaging experiments, cells were plated on glass bottom dishes 
(MatTek Corporation), which had been treated with 1M HCl for 5 min, followed 
by 70% ethanol and PBS wash. Cells were imaged with an ORCA-ER camera 
(Hammamatsu) attached to a Nikon TE2000 microscope with dual Sutter filter 
wheels, a spinning disk confocal head (Yokagawa), a mercury light source and a 
Coherent 70C two watt multi-line laser using 40x/0.95NA Plan Apo Nikon or 
60x/1.4NA Plan Apo Nikon objectives. During time lapse, MTLn3 cells were kept 
at 37°C with aid of a Solent Incubator chamber (Solent Inc.) fitted for the 
microscope. All images were collected, measured and compiled with the aid of 
Metamorph imaging software (Molecular Devices) and Adobe Photoshop. 
 
Membrane protrusion assays 
 
MTLn3 cells were starved for 3-4 hr in L15 medium (Gibco) supplemented 
with 0.35% BSA. For stimulation, cells were treated with a bath application of 
EGF (Invitrogen) at 37°C. Time-lapse movies were recorded for 10 min with a 10 
s interval after the addition of EGF. Area fold change was quantified by cell 
tracing, and cell area was measured using Methamorph software. Area 
measurements of each cell were standardized over the area of the corresponding 
cell at time = 0, averaged and plotted over time after EGF stimulation. For 
kymography experiments, phase-contrast time-lapse sequences movies were 10-
15 min long with frames taken every 3 s. Kymographs were produced and 
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analyzed using Metamorph software. Kymographs were generated along 1-pixel-
wide line regions oriented in the direction of individual protrusions. For 
quantitative analysis, straight lines were drawn on kymographs from the 
beginning to the end of individual protrusion events, neglecting fluctuations <0.5 
µm (2 pixels) in magnitude. Slopes of these lines were used to calculate the 
velocities, and projections of these lines along the x axis (time) were used to 
calculate the persistence of protrusions. 
 
Animal models 
 
Xenograft tumors were derived from subcutaneous injection of 1 × 106 
MTLn3-EGFP, MTLn3-EGFP-Mena, MenaINV, Mena11a and HMLER-splice 
reporter cells into the right abdominal mammary gland (4th fat pad) of 5-7 wk-old 
female SCID mice. MTLn3 experiments were performed following 3-4 weeks of 
tumor growth, while HMLER-splice reporter tumor were harvested when was 
palpable, around 8-10 weeks post injection. 
 
In vivo invasion assay 
 
The in vivo invasion assay was performed as previously described (Wyckoff 
et al., 2000). In brief, six catheterized microneedles containing Matrigel and EGF 
(concentrations varying from 0.0 to 250 nM) were inserted into the primary tumor 
and held in place by micromanipulators. Following 4 hr of cell collection, the total 
number of tumor cells that migrated into each needle was quantified as previously 
described (Wyckoff et al., 2004). At least five mice were used per condition. 
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Recombinant Protein Expression and Purification 
 
All EVH2 proteins were recombinant, His6-tagged and purified from 
Escherichia coli. EVH2 proteins were expressed in E. coli strain BL21 (DE3) 
CodonPlus and purified by chromatography on TALON resin (BD Biosciences) 
and Superdex 200 in MKEI-200 buffer (20 mM imidazole, pH 7.0, 200 mM KCl, 
1 mM EGTA, 2 mM MgCl2, and 1 mM DTT). EVH2 proteins were stored on ice 
and used within 2 weeks of purification. Recombinant murine CP (α1β2) was a 
gift from Dorothy Schafer (University of Virginia). Actin was prepared from 
rabbit muscle as described (Spudich and Watt, 1971) and gel filtered on Superdex 
200 equilibrated in 2 mM Tris/HCl, pH 8.0, 0.2 mM ATP, 0.1 mM DTT, and 0.2 
mM CaCl2. Pyrenyl-actin was prepared as described in Bryan and Coluccio, 1985. 
For TIRF experiments, gel-filtered rabbit skeletal muscle actin was labeled with 
Alexa-488 succinimidyl ester (Molecular Probes). All proteins except actin were 
quantified from absorbance at 280 nm using extinction coefficients predicted from 
the amino acid sequence (PROTEIN CALCULATOR v3.3; 
http://www.scripps.edu/~cdputnam/protcalc.html): His-EVH2-VASP 5690 M-1 
cm-1, His-EVH2-Mena 6970 M-1 cm-1; His-EVH2-Mena11a 8250 M-1 cm-1 
(considered a tetramer). Actin was quantified from absorbance at 290 nm and the 
extinction coefficient of  26.600 M-1 cm-1. 
 
Other Proteins 
 
Michele Balsamo PhD thesis 
 60 
Spectrin F-actin seeds (SAS) were prepared from human erythrocytes as 
described in DiNubile et al., 1995. The concentration of SAS was determined 
from the initial rate of actin polymerization using kon for actin = 11.6 M-1 cm-1, 
assuming no pointed end growth. 
 
Actin pelletting assays 
 
Dialyzed G-actin o/n against G-buffer (2 mM Tris Cl ph8, 0.2 mM DTT, 0.2 
mM ATP, 0.2mM MgCl2) and EVH2 Ena/VASP in MKEI-200 buffer were 
spinned at 250000 X g for 30 minutes before the assay. 4 µM G-actin were 
polymerized for 2h at RT in F-actin buffer (500 mM NaCl, 10 mM MgCl2, 10mM 
EGTA, 100mM Imidazole pH7). 0.5µM of BSA or Ena/VASP proteins in a final 
volume of 40 µl were incubated with 4 µM F-actin for 15 minutes at RT (actin 
binding) or 1h at RT (for actin bundling). Samples were spun for 20 minutes at 
250000 X g (actin binding) or 15000 X g (actin bundling) at 4°C. Pellet from actin 
binding assays were washed once in F-actin buffer and resuspended in SDS 
sample buffer. Pellet from actin bundling assays were resuspended in SDS sample 
buffer. Pellet and supernatants were separate on SDS PAGE and the gel stained 
with Coomassie brilliant blue. 
 
Actin polymerization assays 
 
Seeded polymerization reactions contained 1 µM actin (5% pyrene-labeled), 
0.2 nM SAS, 10 nM CP, Ena/VASP proteins, in 20 mM imidazole, pH 7.0, 100 
mM KCl, 2 mM MgClg, 1mM EGTA, 0.2 mM ATP, and 0.1 mM DTT (MKEI-
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100 buffer). SAS were omitted from reactions monitoring spontaneous actin 
polymerization. Fluorescence of pyrenyl-actin (excitation at 365 nm, emission at 
386 nm) was monitored for 600 s at 25 °C. All components except actin and SAS 
were mixed in MKEI-100 buffer; reactions were initiated by the simultaneous 
addition of actin (primed with 1 mM EGTA and 0.1 mM MgCl2 for 90 s) and 
SAS. The delay between mixing reactants and recording fluorescence was <16 s. 
Initial rates of actin assembly were determined from linear fits of data collected 
during the initial 60 seconds. In control experiments, Ena/VASP did not alter the 
fluorescence of either pyrenyl-G-actin or pyrenyl-F-actin. 
 
Total Internal Reflection Fluorescence Microscopy 
 
Glass coverslips were cleaned and assembled into sample chambers on glass 
slides as described in Kuhn and Pollard, 2005. Chambers were coated for 1 min 
with Ena/VASP, or control protein (Casein, 5mg/ml or BSA 1%) followed by two 
washes with 1% BSA-containing buffer and once with MKEI-100 buffer (20 mM 
imidazole, pH 7.0, 100 mM KCl, 1 mM EGTA, 2 mM MgCl2). TIRF microscopy 
was performed using an Olympus X71 inverted microscope equipped for through-
the-lens total internal reflection illumination by an Argon laser; a 60x, 1.45 NA 
objective lens in combination with a ×1.5 auxiliary lens was used. Image 
acquisition began 30-60 s after flowing the sample into the chamber. Images (0.5-
s exposure) were collected 1 frame/3 s for 200 frames by a Cool-Snap ES CCD 
camera (Photometrics) controlled by Isee imaging software (Innovision). 
 
Filament capture assay 
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Flow chambers were coated for 1 min with 50 nM Ena/VASP, followed by 
blocking twice with 1% BSA and washing once with MKEI-100. Actin filaments 
were assembled from 0.8 µM actin (10% Alexa 488-actin) in imaging buffer 
containing 0.24% methylcellulose for 2-3 min. An aliquot was flowed into the 
chamber, and data were collected at 1 frame/3 s for 200 frames. Interactions of all 
filaments in the field with the surface were scored for the number of barbed end 
(BE) captures, pointed end captures, side interactions, and number of filaments 
not captured. 
 
Filament bundling assay 
 
Flow chambers were coated for 1 min with 1% BSA and washed once with 
MKEI-100. Actin filaments were assembled from 0.8 µM actin (10% Alexa 488-
actin) in imaging buffer containing 0.24% methylcellulose for 2 min together with 
100nM Ena/VASP proteins. An aliquot was flowed into the chamber, and data 
were collected at 1 frame/3 s for 200 frames. 
 
Spreading assay 
 
Spreading assays were performed as described in Applewhite, et al. 2007, 
with modifications. MVD7 EGFP and EGFP-Mena isoforms derivates cells were 
trypsinized and replated on laminin (20 µg/ml) coated coverslips. Cells were 
allowed to spread for 30 min and then fixed with cold methanol for 15 min at -
20°C. Coverslips were washed 2 times with PBS. Afterwards cells were 
permeabilized 3 min at RT with 0.2% Triton-X 100 in PBS, washed 2 times with 
PBS and incubated with mouse monoclonal fascin antibody (1:50; Dako) to stain 
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filopodia. Cells phenotype were analyzed and categorized in cell with filopodia o 
cells without filopodia. 
 
Electron microscopy 
 
Tissues were fixed with 2.5% glutaraldehyde and 2.5% formaldehyde in 0.1 
M sodium cacodylate-HCl, pH 7.2, for 60–90 min at 4°C, postfixed with 2% 
osmium tetroxide for 60 min at 4°C, dehydrated in up to 70% graded alcohol, and 
stained with 0.2% uranyl acetate in 70% alcohol for 60 min at 4°C. The samples 
were then processed for epon embedding. Thin epon sections (400 nm) were cut 
with a diamond knife, poststained with uranyl acetate and Reynold's lead citrate, 
and viewed with an electron microscope (G2 Spirit BioTWIN; Tecnai) operated at 
80 kV. Digital images were taken with a camera (2k CCD; Advanced Microscopy 
Techniques; provided by the Harvard Medical School Electron Microscopy 
Facility). 
 
Statistical analysis 
 
Statistical differences between two conditions were determined using t test. 
For multiple conditions, means were compared by analysis of variance. All data 
found to be significant (P < 0.05) by analysis of variance were compared with 
Tukey's honestly significant difference post hoc test to reveal statistically different 
groups. 
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Mena11a characterization in cancer cell lines 
 
Human Mena11a was identified by RT-PCR performed on cDNAs isolated 
from a human luminal breast cancer cell line expressing high levels of an mRNA 
identified by SEREX technique (serological analysis of recombinant cDNA 
expression libraries) and encoding the human Mena gene (Di Modugno et al., 
2004). Later analyses have shown that Mena11a is a splicing isoform of Mena, 
containing an insertion of 63 base pairs (21 aminoacids). This insertion falls in 
between the F-actin and the tetramerization domain of the EVH2 domain of Mena 
(Figure 5). To gain insight into the distribution and function of Mena11a in cells 
and tissues, we developed a rabbit polyclonal antibody against the first 20 amino 
acid of the human 11a exon (RDSPRKNQIVFDNRSYDSLH) sequence, modified 
with a C-terminal cysteine, needed for the binding of the peptide to a Iodoacetyl-
based resin for the subsequent affinity purification. As shown in Figure 6-A, the 
polyclonal antibody specifically recognizes Mena11a, as determined by Western 
blot analysis on lysates from Ena/VASP deficient cells (MVD7) reconstituted with 
EGFP, EGFP-Mena or EGFP-Mena11a. In cells, Mena11a localizes to the sites of 
active actin remodeling. In facts, it is enriched to the cell-cell junctions of MCF7 
cell, where it colocalizes with adherents junctions markers (E-cadherin) (Figure 6-
B), and in the neo-forming junctions of mouse primary keratinocytes (Figure 6-C) 
after Ca++ switch in the culture media. It also colocalizes with vinculin, a focal 
adhesions marker (Figure 6-D). Moreover, Mena11a is recruited to the leading 
edge of lamellipodia in EGF-stimulated (60 seconds, 0.5 nM EGF) MTLn3 cells 
(Figure 6-E). The localization of Mena11a in the hot-spots of actin polymerization 
suggests a role for Mena11a in the Mena-dependent actin cytoskeleton dynamics.  
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Mena11a is a marker of epithelia 
 
To gain further insights into the fisiological role of Mena11a in vivo, we 
conducted immunofluorescence analysis on mouse tissues harvested from E10.5 
Figure 6. Mena11a distribution in epithelial cells. A) Mena11a antibody recognizes specifically 
Mena11a and not Mena in lysates from Ena/VASP deficient cells reconstituted with EGFP-tagged 
Mena isoforms. B) Mena11a localizes to the cell-cell junctions of MCF7 cells and neo-forming 
junctions of normal primary mouse keratinocytes, 3h after calcium switch in the culturing media (C). 
D) Mena11a colocalizes with vinculin to focal adhesions in MCF7 cells. E) Mena11a is recruited to 
the leading edge of MTLn3 cells during EGF treatment (60 seconds, 0.5 nM EGF). p34ARC is a 
subunit of the Arp 2/3 complex, used as leading edge marker. Color code as indicated in the Figure. 
Magnification 60x. 
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(embryonic days post coitum), E13.5 and adult. We found striking differences in 
Mena11a and Pan-Mena localization. In the developing gut of E10.5 mouse 
embryos, Mena11a is exclusively expressed in the epithelium while Pan-Mena is 
also enriched in the surrounding mesenchyme (Figure 7-A). In the developing 
epidermis of E13.5 embryos (Figure 7-B) Mena11a is enriched in the 
keratinocytes while pan-Mena is also expressed in the underlying mesenchyme. In 
adult tissues Mena11a is expressed and localized to the basal layer of 
keratinocytes in the mouse skin (Figure 7-C) and in the bronchiole epithelium in 
the lungs (Figure 7-D). The broad expression of Mena11a in different epithelia 
strongly supports Mena11a as a marker of the epithelia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 7. Mena11a is enriched in epithelial tissues. A) Mena11a (green) is expressed and 
localizes in the developing gut of E10.5 mouse tissue while Pan-Mena (red) in also enriched in 
the surrounding mesenchyme. B) Mena11a is enriched in the developing epidermis and in the 
adult epidermis (C); D) Mena11a is abundant in the lung bronchiole epithelium of adult mice. 
Magnification 40x. 
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Mena11a is downregulated during the Epithelial to Mesenchymal Transition 
(EMT) 
 
EMT is a process believed to be involved in the metastatization of epithelial 
cancers. We screened a large panel of cancer cell lines, epithelial (mammary and 
pancreatic cancers) and non epithelial (glioma and melanoma), for Mena11a 
expression together with epithelial (E-cadherin) or mesenchymal (N-cadherin and 
vimentin) markers. Mena11a is expressed in breast (Figure 8-A) and pancreatic 
(Figure 8-B) cancer cell lines with an epithelial phenotype (E-cadherin expression 
and “low invasive and metastatic potential” as referred in the literature) and is 
downregulated in the breast and pancreatic cells that concomitantly downregulate 
E-cadherin and upregulate N-cadherin and vimentin. Of note, non-epithelial 
cancers such as melanoma (Figure 8-C) and glioma (Figure 8-D), while 
expressing Mena, don’t express Mena11a. In order to confirm that Mena11a is 
indeed downregulated during EMT we adopted an established EMT model of 
immortalized human mammary epithelial cells overexpressing the transcription 
factor Twist, that drives the transition from an epithelial-like to a mesenchymal-
like phenotype (Yang et al., 2004). Mena11a is downregulated at the mRNA and 
protein levels in HMLE-pBP-TWIST, compared to the HMLE-pBP control cell 
line (Figure 8-E). To look at the kinetics of Mena11a downregulation, we used a 
modified HMLE EMT system. In this model, EMT is induced by treatment with 
4-hydroxy tamoxifen (4-OHT, final concentration 20nM) of HMLE cells 
expressing a fusion protein Twist-ER. Following 4-OHT treatments, HMLE-
Twist-ER cells develop a mesenchymal morphology similar to HMLE cells stably 
expressing Twist (not shown). HMLE-Twist-ER cells were treated with 4-OHT 
up to 17 days and total cell lysates were collected every 2 days. Upregulation of 
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N-cadherin is observed around day 7 with a progressive increase until day 17. E-
cadherin protein level is drastically downregulated after day 11, showing 
undetectable levels at day 17, confirming the classical “cadherin switch”. Of 
interest, while Pan-Mena protein level did not change, progressive 
downregulation of Mena11a is observed after day 11 until day 17, strongly 
suggesting a contribution for this Mena isoform in the regulation of the epithelial 
phenotype in mammary cells. DMSO treatment of the HMLE-Twist-ER cells 
doesn’t affect protein expression levels of N-cadherin, E-cadherin and Mena 
isoforms (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Mena11a is 
downregulated during 
EMT. Mena11a is 
downregulated in human 
breast cancer (A) and 
human pancreatic cancer 
cell lines (B) that express 
mesenchymal markers. 
Mena11a is not expressed 
in human melanoma (C) 
and glioma (D) cell lines. 
E) Mena11a is 
downregulated in HMLE-
Twist cells, both at mRNA 
(upper) and protein (lower) 
level.  
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Mena11a is expressed in mammary cancer-derived metastases  
 
In view of the finding that Mena11a is downregulated during the EMT 
process, we next asked whether Mena11a could be expressed in metastases from 
mammary cancers. We adopted the MMTV-PyMT mouse model to analyze Mena 
isoform expression in the primary tumor and in the lung metastases. MMTV-
PyMT transgenic mice express the mouse polyomavirus middle-T antigen 
(PyMT) under the control of the mouse mammary tumor virus (MMTV) long 
terminal repeat. These transgenic animals uniformly develop multifocal mammary 
tumors with a high incidence of pulmonary metastases (Guy et al., 1992). 
Comparative studies have shown that the PyMT mouse model is an excellent 
model to understand the biology of mammary tumor progression, resembling in 
many aspects the human pathology (Lin et al., 2003). 
Immunofluorescence analysis on paraffin-embedded primary tumors and 
lung metastases reveals a broad overlap in localization of Mena and Mena11a in 
the primary tumor (Figure 9-A), while the localization in the lung metastases was 
not completely overlapping. As shown in Figure 9-B, smaller is the metastasis 
less defined is the Mena11a localization to the cell-cell junctions of the metastatic 
cells. Mena11a localization to the cell-cell contacts is more pronounced in bigger 
metastases. Of note, Pan-Mena already localizes to the cell-cell junctions of the 
micrometastasis. It is tempting to speculate that Mena11a is down-regulated in the 
invasive cells that intravasate from the primary tumor to the systemic circulation 
and needs to be re-expressed gradually, once the metastatic cells extravasate from 
the capillary bead and infiltrate in the lung parenchyma. We are quantitatively 
correlating Mena11a and Mena localization to the cell junctions in metastasis of 
different sizes. 
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Figure 9. Mena11a expression in primary tumor and metastases of MMTV-PyMT 
mouse. A) Immunofluorescence analysis of mammary tumor and lung metastases (B) of 
MMTV-PyMT mouse. Note the difference in localization to the cell-cell junctions in the 
micrometastasis, between Pan-Mena (green) and Mena11a (red). Samples were harvested 
4 months after birth. Magnification 40x. 
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Mena11a is downregulated specifically in invasive carcinoma cells 
 
Previous data have shown that Mena isoforms are expressed differently in 
cells collected after an in vivo invasion assay performed in MMTV-PyMT mice 
(Goswami et al., 2009). In this assay, a micro needle filled with collagen and EGF 
is inserted in the mammary tumor of MMTV-PyMT mice. Invasive cells 
chemoactratted by a stable gradient of EGF are collected and plated on a coverslip 
for immunofluorescence analysis, using Pan-Mena, Mena11a, E-cadherin and 
vimentin antibodies. Invasive cells up-regulate Pan-Mena protein almost 3 fold 
(P<0.0002) compared to the average primary tumor cells (APTC), while 
downregulating Mena11a almost 3.75 folds (P<0.005). Interestingly, concomitant 
with the changes in Pan-Mena and Mena11a is the upregulation of the 
mesenchymal marker vimentin (almost 2 folds). No significant changes in E-
cadherin levels were observed. Together these data suggest a temporally-defined 
expression of Mena11a during primary tumor formation, extravasation and 
metastatic dissemination and subsequent re-epithelialization during the 
colonization of secondary sites by metastatic cells. The latter process is often 
called Mesenchymal to Epithelial Transition (MET), but this is a phenomenon 
that is not yet fully investigated and understood. 
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Mena11a dampens the EGF-mediated cell protrusion in carcinoma cells 
 
      Recent data from Frank Gertler laboratory have shown a role for Mena in 
potentiating the EGF-mediated carcinoma cells protrusion, invasion and 
metastasis (Philippar et al., 2008). Mammary carcinoma cells respond to EGF 
treatment by the increasing actin polymerization that drives circumferential 
lamellipodia extension (Figure 10-A). This a pathway starts from EGFR and 
propagates through the release of cofilin from the cell membrane by hydrolysis of 
PIP2 mediated by PLC-γ. Activated cofilin severs actin mother filaments to 
produce free barbed ends leading to the elongation of newly polymerized actin 
filaments that are preferred for dendritic nucleation by the Arp 2/3 complex. We 
stably overexpressed EGFP, EGFP-Mena and EGFP-Mena11a in MTLn3 
mammary carcinoma cells (Figure 10-B) and followed the EGF-mediated 
membrane protrusion of individual cells by time-lapse microscopy for 10 minutes, 
using sub-saturating concentrations of EGF (0.5 nM). A striking phenotype in the 
Mena11a-overexpressing cells was observed: while Mena overexpression induced 
a potent membrane protrusion with a flat lamellipodium, Mena11a overexpressing 
cells didn’t spread as well being the protrusions similar to the ones observed in 
the EGFP control cells. Moreover, several unproductive protrusions were 
observed in the Mena11a overexpressing cells (Figure 10-C). The quantification 
of the cell area shows that Mena 11a dampens the EGF-mediated lamellipodia 
protrusion in MTLn3 cells (Figure 10-D). This observation was confirmed at 
different EGF concentrations, ranging from 1 to 0.06 nM (Figure 10-E).  
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Figure 10. Mena11a dampens the EGF-mediated membrane protrusion in carcinoma cells. 
A) Effect of EGF stimulation (0.5 nM, 60 seconds) on MTLn3 cells (red, phalloidin,; green, 
EGFP-Mena). B) Levels of stable overexpression of EGFP-Mena11a, EGFP-Mena and EGFP in 
MTLn3 cells. C) Time lapse of  MTLn3 cells, stimulated with 0.5 nM EGF. D) Time course 
quantification of the membrane protrusions. E) EGF dose-response curve quantification of the 
membrane protrusions at 3 minutes post stimulation. Asterisks indicate p< 0.05 versus EGFP-
MTLn3 at each EGF concentration as determined by a Kruskal-Wallis non-parametric test, 
followed by post-processing with a Scheffe test.  Data are shown as mean ± standard deviation 
and from three independent experiments. More that 120 cells were quantified per each 
experiments in panel D and E. 
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Mena11a-mediated lamellipodia extension doesn’t results in productive 
protrusions 
 
A detailed kinetic analysis of lamellipodia protrusions was performed by 
kymography. A kymograph is a montage created by extracting intensity values 
along a defined line region in each image of a time-lapse series and pasting them 
side-by-side to generate a composite image of object movement over time. In our 
analysis, we used a 1-pixel-wide line drawn in the direction of cell protrusion. The 
resulting kymographs reveal the dynamics of membrane activity at a single point 
along the cell perimeter. Analysis of such kymographs permits quantification of 
membrane extension rates and determination of the average time the membrane is 
engaged in individual protrusions. EGF treatment in control cells causes cycles of 
protrusion and withdrawal that generate a net extension of the membrane 
protrusion. Forced overexpression of Mena confers fewer cycles of membrane 
protrusion and withdrawal, and a potent membrane extension. Overexpression of 
Mena11a almost inhibits the effect of EGF treatment on the membrane protrusion 
in these carcinoma cells (Figure 11-A). Quantification of membrane velocity and 
persistency show a reduction in the mean velocity (8.7 um/sec vs. 4.7 um/sec in 
Mena and Mena11a, respectively; P<0.001) and mean persistency (7.6 sec vs. 4 
sec in Mena and Mena11a, respectively; P <0.01) (Figure 11-B). Thus, Mena11a 
has a role in the regulation of the actin cytoskeleton dynamics during cell 
protrusions.  
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Mena11a is in a complex with Mena 
 
The fact that Mena11a overexpression impairs while Mena overexpression 
potentiates membrane protrusions can be due to a different compositions of the 
tetramers formed, acting on the actin cytoskeleton remodeling. In fact, 
endogenous Mena11a is found in complex with EGFP-Mena in MTLn3 EGFP-
Mena cells. As shown in Figure 12-A, EGFP-Mena co-immunoprecipitates with 
Mena11a antibodies but not with rabbit control antibodies, Furthermore, 
endogenous Mena11a co-immunoprecipitatates with EGFP-Mena upon 
immunoprecipitation with EGFP antibodies. This interaction is between Mena and 
Mena11a and is not dependent upon binding of the EGFP tag with endogenous 
Figure 11. Kymography of EGF stimulated carcinoma cells. A)Representative kymographs of  
MTLn3 cells stably overexpressing EGFP, EGFP-Mena and EGFP-Mena11a. Kymographs show 
lamellipodia activity along the lines in phase contrast images. The red vertical line indicates the 
time when EGF (5 nM for 10 minutes) was added. B) Box and whisker plots for velocity (∆Y/∆X) 
and persistance (∆X) of individual events of protrusion for the different cell lines. Dot indicates 
mean, middle line of box indicates median, top box indicates 75th quartile, bottom box indicates 
25th quartile, and whiskers indicate extent of 10th and 90th percentile, respectively. Data in panel B 
come from 103 events of protrusion in 80 cells per each cell line. ANOVA values, followed by 
post-processing with Tukey post test are indicated in the Figure. 
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Mena11a, since Mena11a is not immunoprecipitated by EGFP antibodies in 
protein lysates from MTLn3-EGFP cells (Figure 12-B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mena11a overexpression decreases carcinoma cells invasion in vivo  
 
Cancer cell motility and invasion in response to chemotactic stimuli is the 
first step in the metastatic process. To mimic the in vivo invasion step, John 
Condeelis laboratory developed an in vivo invasion assay, in which cells with 
invasive potential within a tumor are chemoattracted by a gradient of EGF and 
collected in microneedles filled with EGF-collagen. In the in vivo invasion assay 
cells can only enter the needles by active migration since a block is used to 
prevent passive collection of cells and tissue during insertion of the needle into 
Figure 12. Endogenous Mena11a is in complex with EGFP-Mena. Cell lysates from either 
MTLn3 EGFP-Mena (A) or MTLn3 EGFP (B) were incubated with anti GFP, anti Mena11a 
and rabbit or mouse control antibodies and immunoprecipitated. Samples were then analyzed 
via SDS-PAGE and Western blotting with the antibodies indicated in the Figure. 
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the tissue. The block is removed and cell migration can be observed using 
multiphoton microscopy. Active migration has been demonstrated to be required 
for cell collection (Wang et al., 2004). MTLn3 cells stably overexpressing EGFP-
control and different EGFP-tagged Mena isoforms were injected in the mammary 
fat pad of NOD/SCID mice. When the tumor reached 1.2-1.5 mm in diameter 
(around 4 weeks post-injection), the in vivo invasion assay was performed. The 
number of MTLn3-Mena11a cells collected in the needle at different 
concentration of EGF is statistically lower compared to Mena and MenaINV (a 
Mena Invasive isoform) overexpressing cells and, when concentrations of EGF 
higher than 1 nM were used, the difference was significant also compared to the 
EGFP control cells (Figure 13). Thus Mena11a can block the in vivo invasion of 
carcinoma cells. The analysis of metastases in these mice is still an on-going 
experiment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Mena11a overexpression decreases carcinoma cell invasion in vivo. In vivo 
invasion assay: EGF dose response curve of invasive cells collected from the MTLn3 cell tumors 
(indicated in the figure). Data normalized to average number of cells per needles containing 0.0 
nM EGF for each type of xenograft. Errors bar indicates SEM. (Thank to E. Roussos, Condeelis 
lab). 
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The EVH2 domain of Mena11a has an F-actin binding and bundling activity 
 
Ena/VASP are actin cytoskeleton regulatory proteins and several modes of 
actin remodeling have been shown. The EVH2 domain has been found to be the 
essential domain for actin remodeling and in cells, and EVH2 domain itself is able 
and sufficient to rescue all the different phenotypes of an Ena/VASP loss, 
suggesting an essential role of this domain for Ena/VASP function (Applewhite et 
al., 2007; Bachmann et al., 1999; Barzik et al., 2005; Bear et al., 2002; Loureiro et 
al., 2002). The site of insertion of the 11a exon in the EVH2 domain, between the 
F-actin binding site and the tetramerization domain, inspired us to perform 
experiments to investigate the involvement of Mena11a in the actin dynamics. 
First we cloned the full length of Mena, Mena11a and VASP in vectors containing 
a tandem of two C-terminal tags needed for the purification of the recombinant 
protein in affinity chromatography columns, a poly-histidine tag (HIS tag) and a 
strept-tag, a tag that can bind an engineered streptavidin. The functionality of 
these vectors were tested in filopodia-formation assays, showing the rescue of the 
loss of filopodia-spreading phenotype in MVD7 cells (not shown). Next we 
performed affinity purification chromatography with lysates of HEK-293 cells 
transfected with VASP-His, Mena-His and Mena11a-His vectors. We were able to 
purify the full-length of VASP, Mena and Mena11a from these cells but 
unfortunately not in sufficient amounts needed to perform biochemistry 
experiments (not shown). Therefore, we cloned the EVH2 of VASP, Mena and 
Mena11a in plasmids to express N-terminal his-tagged proteins in E. Coli and we 
purified actin from rabbit muscles. The late-shoulder of actin and recombinant 
proteins were collected by gel filtration chromatography on a SD-200 column. 
The quality of the purified actin was tested in F-actin polymerization assays (not 
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shown). Next we tested the recombinant proteins in actin pelletting assays, testing 
the ability of the recombinant proteins to bind (high speed centrifugation) F-actin 
and to bundle (low speed centrifugation) F-actin, as described in the materials and 
methods. The EVH2 domain of Mena11a binds (upper panel) and bundles (lower 
panel) F-actin in solution (Figure 14-A). Moreover, the bundling formation of 
Mena and Mena11a has been observed directly by Total Interference Reflection 
Fluorescence (TIRF) microscopy experiments, where 10% of the total actin was 
labeled with Alexa 488 (Figure 14-B). As negative control, bovine serum albumin 
was used and infact no effects on actin were observed, confirming that the 
pelletting of the Ena/VASP recombinant protein is not an aspecific binding to 
actin. Thus, the 11a insertion doesn’t seem to affect the actin binding and 
bundling activity of Mena11a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Mena11a has binding and bundling activity.  A) Actin pelletting assays: BSA and 
the EVH2 domain of Mena11a, Mena and VASP were incubated with F-actin filament and 
subjected to high speed (binding assays, upper panel) or low speed (bundling assays) 
centrifugation. Pellets and supernatants are loaded on an SDS-PAGE and visualized by 
Coomassie brilliant blue staining. B) BSA and EVH2 domain of Mena11a, Mena and VASP were 
incubated with F-actin (10% Alexa488 labeled) and analyzed by TIRF microscopy. Magnification 
60X.  
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EVH2-Mena11a has an anti capping activity as potent as EVH2-Mena in 
pyrene actin assays 
 
The most accepted function of Ena/VASP is the so called “anti capping” 
activity, which allows actin-filaments elongation, even in presence of high levels 
of capping proteins (Barzik et al., 2005; Bear et al., 2002). In vitro, the anti 
capping activity of Ena/VASP has been tested using purified proteins and actin 
labeled with pyrene, a polycyclic aromatic hydrocarbon that increases its 
fluorescence once incorporated in actin filaments. We purified Spectrin-Actin 
Seeds (SAS) from human eritrocytes, which are needed to “prime” the initial 
polymerization. The anti capping activity of Mena11a was tested by this assay. As 
shown in Figure 15-A the EVH2 domain of Mena11a, similar to Mena, protects 
actin filaments barbed ends from capping in a dose-dependent manner (in a 
fisiological nanomolar range of Ena/VASP). In control assays, the elongation of 
actin filaments (no capping proteins added) was negligible (Figure 15-B). 
Moreover, the spontaneous nucleation of actin by Mena and Mena11a was also 
negligible under the conditions used in the assay (not shown). These data needs 
further confirmation addressing the question of the anti capping activity of 
Mena11a by TIRF microscopy. Indeed, one drawback of these otherwise highly 
effective pyrene-actin assays is the difficulty to discriminate between an increased 
nucleation and elongation rate of filaments during polymerization. In other words, 
many nucleating filaments that elongate slowly may give the same fluorescence 
signal as a few rapidly elongating filaments.  
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Figure 15. EVH2-Mena11a inhibits barbed end capping by capping proteins. A) EVH2 
domain of Mena 11a (upper left) and Mena (upper center) increase the rate of actin 
polymerization in the presence of capping proteins (CP) in a dose dependent manner. Plotted is 
the fluorescence of pyrenyl-actin versus time in the reactions containing 1µM actin (5% pyrene 
labeled), 0.2 nM Spectrin Actin Seeds (SAS) (blue line), 10 nM CP and various amounts of 
EVH2-Mena and EVH2-Mena11a. Initial rates (upper right) were calculated from a linear fit to 
the first 60 seconds of each time course and normalized to the initial rate in the reaction 
containing SAS alone. B) EVH2 domain of Mena 11a (bottom left) and Mena (bottom right) 
don’t increase the rate of actin polymerization. Plotted is the fluorescence of pyrenyl-actin 
versus time in the reactions containing 1µM actin (5% pyrene labeled), 0.2 nM Spectrin Actin 
Seeds (SAS), and various amounts of EVH2-Mena and EVH2-Mena11a (no CP is added in 
these assays). 
Michele Balsamo PhD thesis 
 83 
Mena11a has an impaired barbed ends capture activity 
 
We examined how the EVH2 domains of Mena and Mena11a influence the 
capture of the barbed ends of growing actin filaments by TIRF microscopy. 
Figure 16-A shows the schematic of the assay. We coated coverslips with 50 nM 
of the EVH2 of Mena or Mena11a, using as positive control coverslips coated 
with the same concentration of EVH2-VASP and as negative control 5 mg/ml of 
casein. Alexa488-actin (10% labeled) was primed for 1 minute and then flowed in 
the imaging chamber. Filaments initially diffused freely within the evanescent 
field. Gradually, filaments stopped diffusing freely and became tethered at the 
surface via attachment by their barbed ends (Figure 16-B). Once captured, end-
attached filaments paused briefly before resuming their grow within 12 seconds. 
Captured filaments remained bound to the surface via an interaction along the side 
of the filament at the initial side where the barbed end capture had occurred. For 
VASP and Mena, the captured filaments was frequently captured again at the 
other sites on the surface as the filament continued to elongate, while Mena11a 
and casein didn’t bind the barbed end that efficiently (Figure 16-C). On average, 
filaments experienced 1.43±0.30 BE capture/filament for VASP-coated 
coverslips; 1.78±0.34 BE capture/filament for Mena; 0.95±0.39 BE 
capture/filament for Mena11a and 0.58±0.46 for casein-coated coverslips. Of 
importance, as reported in table1, the percentage of non-attached filament was 
10.3 fold less in Mena11a coated-coverslips compared to the Mena-coated ones. 
Moreover, the interaction of the actin filaments with the coated surfaces was 
prevalently through the barbed end and not through the pointed end or a side 
capture (Table1).  
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Collectively these data suggest a precise function for the 11a insertion in the 
EVH2 domain in the regulation of the initial capture of the barbed end in growing 
actin filaments and ultimately in the dynamics of actin polymerization mediated 
by Ena/VASP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. EVH2-Mena11a doesn’t capture actin filament barbed ends. A) Schematic of the 
barbed end capture assay. B) Time lapse series showing capture of filaments by a EVH2-Mena 
coated surface using TIRF microscopy. White arrowheads mark the initial barbed end capture 
event, red arrowheads mark the old captured ends, now bounded by the side of the EVH2 
molecule. B) Number of barbed end captures per filament efficiency by 5mg/ml casein or 50 nM 
EVH2-Mena11a, Mena or VASP. Error bars indicate standard deviation. ANOVA values, 
followed by post-processing with Tukey post-test are indicated in the Figure. The number of 
filaments scored and the different events are indicated in Table 1. 
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Table 1. Interactions of actin filaments with casein, EVH2-VASP, Mena and 
Mena11a-coated surfaces. 
BE, barbed end; PE, pointed end. Data compiled from 3 independent experiments. 
  
 
 
 
 
 
 
 
 
Mena11a expressing cells have an impaired filopodia formation 
 
Ena/VASP exerts an important role for filopodia formation both in cultured 
cells and in vivo (Applewhite et al., 2007; Dent et al., 2007; Kwiatkowski et al., 
2007; Lebrand et al., 2004). To study protrusion and filopodia formation, we used 
cell spreading as model system. Spreading cells are particularly protrusive and 
have many characteristics in common with migrating cells. We used Ena/VASP 
deficient cells to generate cells stably expressing EGFP, EGFP-Mena or EGFP-
Mena11a. Ena/VASP deficient cells (MVD7) spread on laminin-coated coverslips 
with three different modes: smooth-edged, filopodial and ruffling (Figure 17-A). 
We focused our attention to the percentage of cells that spread with a filopodia 
phenotype, and scored the filopodia-making cells using a specific marker for 
genuine filopodia (fascin). As reported by others (Applewhite et al., 2007), Mena 
expression in MVD7 rescues the loss of filopodia spreading-mode phenotype of 
the null cells. Infact, the population of cells with filopodia raises from 12% to 
38%, when Mena is expressed (P<0.001 between EGFP and EGFP-Mena cells). 
Interestingly, the percentage of Mena11a-expressing cells making filopodia was 
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statistically lower (P<0.01 between Mena and Mena11a expressing cells), 
dropping from 38% to 20% (Figure 17-B).  
This observation is important since filopodia initiation and formation needs 
both barbed ends capture and anti capping activity of Ena/VASP (Svitkina et al., 
2003). Therefore the lack of barbed end capture activity can influence the overall 
activity of tetramers of Ena/VASP containing Mena11a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Mena11a expressing cells have an impaired filopodia formation. A) Three 
characteristic spreading phenotypes of Ena/VASP deficient mouse embryonic fibroblasts, 20 
minutes after spreading on laminin coated coverslips (20 µg/ml). Cells are fixed and stained with 
phalloidin or fascin antibodies. B) Quantification of the percentage of cells spreading with 
filopodia, per each MVD7 cell line. ANOVA values, followed by post-processing with Tukey 
post-test, are indicated in the Figure. 390 cells per each cell line, over 3 independent 
experiments, were analyzed. 
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This PhD work is aimed to understand the role of Mena11a, an alternatively 
spliced isoform of Mena, in cancer cell motility and epithelial morphogenesis. 
Mena is a member of the Ena/VASP family of actin cytoskeleton regulatory 
proteins, and is involved in several actin-based processes that are often 
deregulated in cancer and lead to metastatic disease.  
 
Mena11a is a marker of the epithelial phenotype and is downregulated 
during EMT 
 
Mena is upregulated in human breast cancer patients and in invasive rodents 
cells in vivo (Di Modugno et al., 2006; Wang et al., 2004; Yang et al., 2004). 
Moreover, Mena gene has been found to be alternatively spliced and recent 
observations are shedding the light on the role of these alternatively spliced 
isoforms. Alternative splicing of genes has been analyzed in great detail in the 
past years, but the specific function of these alternative transcripts is still a black 
box for most of the genes. By a deep sequencing of cDNA fragments from 15 
human tissues and breast cancer cell lines, Chris Burge laboratory has found that 
92-94% of human genes undergo alternative splicing (Wang et al., 2008), 
meaning that splicing events are a nearly universal mechanism of gene regulation. 
Several isoforms has been identified for Mena (Di Modugno et al., 2007; Gertler 
et al., 1996) (Figure 5), some of them like Mena+, seem to be a nervous system-
specific isoforms even if may be also enriched in invasive and metastatic cancer 
cells (F. Gertler, personal communication). Another interesting isoform of Mena 
(MenaINV) has been described to be specifically upregulated in invasive cancer 
cells (Goswami et al., 2009) (Philippar et al., 2008). MenaINV overexpression 
enhances the metastatic potential of mammary carcinoma cells, and enhances the 
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invasion in 3D collagen matrices. Moreover MenaINV sensitizes carcinoma cells 
to EGF, enabling cellular responses, such as lamellipodia protrusion and invasion. 
Much lower EGF concentrations are required for there effects in MenaINV cells 
as compared to the parental cell line. The INV insertion (initially refered as +++) 
is right after the EVH1 domain, and is a small 13 aminoacids sequence. The 
molecular mechanisms of the EGF-mediated potentiation of cell protrusion and 
invasion by MenaINV are still unknown. It is curious that in the original paper 
from Frank Gertler (Gertler et al., 1996), the +++ exon was always found together 
with the + exon and never alone. Further studies on the role of the +++/+ isoform 
are ongoing in the Gertler laboratory and this isoform could be the real INV 
isoform identified by the Condeelis lab in invasive cells. Conversely, our major 
contribution in the understanding of the role of Mena11a is that this isoform 
maintains a  “low invasive” phenotype in cancer cells. We identified Mena11a 
from an epithelial-like breast cancer cell line and further characterized this Mena 
isoform (Di Modugno et al., 2007). Mena11a overexpression in breast cancer cell 
lines conferred an increased proliferation rate and induced MAPK activation, 
suggesting a role for this isoform in the proliferation of mammary cancer cells. 
However, the functional mechanism of this increase in proliferation by Mena11a, 
and whether this could be a new function of Ena/VASP proteins in cancer, is still 
under investigation. Of major interest for pancreatic cancer, we identified 
Mena11a as a marker of sensitivity to EGFR inhibition by tyrosine kinase 
inhibitors (Pino et al., 2008). We also found that Mena11a expression correlates 
with the epithelial phenotype of breast and ductal pancreatic adenocarcinoma 
cells, while it is downregulated in cell lines that express mesenchymal markers, 
like vimentin and N-cadherin. Therefore, since Mena11a appears as a new marker 
for the Epithelial to Mesenchymal Transition status of cancer cells, we 
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investigated more in details the contribution of Mena11a in the EMT proces. We 
adopted an EMT model developed by Robert Weinberg’s group, in which the 
transcription factor Twist drives the upregulation of mesenchymal genes that are 
important to confer metastatic behavior of mammary cells (Yang et al., 2004). Of 
interest, Mena is in the top 10 genes upregulated in the metastatic cells compared 
to the non-metastatic one. In the immortalized human mammary epithelial cells 
overexpressing Twist, Mena11a is downregulated together with E-cadherin, while 
at the same time N-cadherin and vimentin are upregulated. Hence, the 
downregulation of Mena11a and E-cadherin are both involved in the acquisition 
of a more spindle-like morphology and a more invasive and metastatic behavior. 
We think that Mena11a is necessary in order to keep an epithelial phenotype in 
normal and epithelial cancer cells, probably acting on the regulation of the 
Ena/VASP-dependent actin cytoskeleton dynamics. Infact, Mena11a is highly 
expressed in normal mouse epithelial tissue during the development and through 
the adult life (Figure 7). For example, Mena11a decors the layer of keratinocytes 
in the developing skin, while pan-Mena is expressed all over the skin epithelium 
and the underlying mesenchyme, suggesting an important role for this Mena 
isoform in the normal development of epithelia.  
Mena expression was found to be progressively upregulated, from benign 
lesions to metastatic tumors, in breast cancer patients. A significant direct 
correlation with tumor size, proliferation index, and HER-2 overexpression and an 
inverse relationship with estrogen and progesterone receptors has been found in 
invasive carcinomas (Di Modugno et al., 2006). This study was conducted using 
an antibody recognizing all Mena isoforms, so the question regarding the dynamic 
expression of different Mena isoforms and the relative contribution of each 
isoform during cancer progression is still unresolved and will need further studies. 
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We wondered if Mena11a is also overexpressed in the primary tumor of 
transgenic mouse model for mammary cancer. We adopted the MMTV-PyMMT 
transgenic mice model, that express the mouse polyomavirus middle-T antigen 
(PyMT) under the control of the mouse mammary tumor virus (MMTV) long 
terminal repeat. These transgenic animals uniformly develop multifocal mammary 
tumors with a high incidence of pulmonary metastasis (Guy et al., 1992), 
histologically recapitulating the key steps of the human mammary disease, from 
adenoma to carcinoma and metastasis (Lin et al., 2003). In needs to be highlighted 
here that the initial steps of carcinogenesis may be different between the human 
tumors and this mouse model, and the PyMT is not expressed in human breast 
tumor cells. However PyMT acts as a potent oncogene activating several signal 
transduction pathways, including those of the Src family and the Ras and PI3 
kinase pathways, which are also altered in human breast cancers, making this 
model suitable for our study. In addition, in PyMT mice mammary glands the 
expression of PyMT is found to be associated with an increased c-myc level and 
this gene is located in one of the three chromosomal regions amplified in human 
primary breast cancers. Remarkably, in the PyMT model the loss of estrogen and 
progesterone receptors (ERs and PgRs), and overexpression of ErbB2/Neu and 
cyclin D1 are observed, similarities to what is observed in human breast cancer 
with poor prognosis. Immunofluorescence analysis shows that Mena11a is highly 
expressed in the primary tumor and colocalizes with Pan-Mena (Figure 10). 
Conversely, Pan-Mena is expressed also in the tumor stroma rich in fibroblasts, 
myoepithelial cells and endothelial cells, confirming one more time that Mena11a 
expression is restricted to the epithelial tumor and not to the stroma. Since 
Mena11a is highly expressed in the primary tumor and is downregulated in cancer 
cell lines that underwent EMT, we asked next if Mena11a was also expressed in 
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the mammary cancer lung metastases in the same mouse model. Interestingly, we 
found a more defined Mena11a expression at the cell-cell junctions of the 
macrometastases compared to the little micrometastases, while Pan-Mena 
expression remained unchanged (Figure 10). It is tempting to speculate that little 
metastases are formed by “newly arrived” cancer cells colonizers of the lung 
parenchyma, while bigger metastasis are formed by “older” colonizers. Thus, we 
can imagine that Mena11a, being downregulated in order to allow the migration 
and invasion of cancer cells from the primary tumor to the metastatic sites (EMT), 
gets upregulated once the metastatic cells need to reform an epithelium in the host 
tissue (MET). A further consideration needs to be done here: even if the mouse 
model system that we used is a transgenic model of overexpression of an 
oncogene, and several multifocal tumors arise in the different mammary fat pads, 
no heterogeneity among cells in terms of up or down regulation of the signaling 
pathways necessary for the primary tumor formation has been shown and 
confounding variations across individual cancer cells and individual mice are 
minimal in MMTV-PyMT mouse model (Herschkowitz et al., 2007). The finding 
that Mena11a is expressed in metastases is in contrast with previously published 
data regarding Mena isoforms mRNA in the primary tumor, invasive cells and 
metastasis in the MMTV-PyMT mouse model (Goswami et al., 2009). The 
authors could not identify any Mena11a transcript in the lung metastases and they 
suggest that Mena11a is downregulated in the metastases. However, the lung 
samples for the mRNA extraction was collected not capturing or isolating the 
metastatic nodules but shedding the lung tissues with a needle and filtering twice 
through nylon filters to obtain single cells. At the contrary, we careful 
microdissected the metastases from the lung parenchyma and we were able to 
detect Mena11a expression by RT-PCR. Data suupporting the hypothesis of a 
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temporally defined Mena11a expression during primary tumor formation, 
invasion and metastasis come from the in vivo invasion experiment, performed on 
the MMTV-PyMT tumors. It was shown already by Goswami and colleagues that 
invasive cells chemoactratted by EGF-filled microneedles downregulate Mena11a 
and upregulate MenaINV isoforms at the mRNA level. We confirm these findings 
in this thesis also at the protein level (Figure 11). Infact we find a 3 fold 
upregulation of Pan-Mena and a 3.75 fold downregulation of Mena11a in the 
invasive cells compared to the primary tumor cells. Interestingly, we also found 
that the downregulation of Mena11a is associated with the upregulation of 
vimentin, a marker of EMT, confirming that invasive cells gain mesenchymal 
features compared to non-invasive cells. About the splicing regulations of Mena 
isoforms, recently Russ Carstens laboratory identified two splice factor proteins 
ESRP1 and ESRP2 as regulators of the epithelial splicing. Among several other 
genes analyzed the splicing of Mena11a seems to be regulated by these two 
splicing factors (Warzecha et al., 2009a; Warzecha et al., 2009b). Interestingly, 
any other exon of Mena doesn’t seem to be regulated by ESRPs. Two other 
investigators have found splicing factors that may regulate Mena11a splicing. 
Kalsotra and colleagues have found that during mouse and chicken heart 
development, the exon11a is gradually included from E14 to adult and the 
splicing may be regulated by CUGBP and ETR-3-like factors (CELF), 
muscleblind-like (MBNL) and Fox proteins, even if the direct splicing of 11a 
inclusion has not been shown (Kalsotra et al., 2008). Yeo and colleagues have 
identified Fox2 as splicing factor in human embryonic stem cells (hESC) that, if 
depleted, resulted in the exon 11a skipping. Interestingly, at mRNA level, about 
80% of total Mena transcript in hESC is Mena11a (Yeo et al., 2009). To gain 
insight into the splicing regulation of Mena11a and to monitor the splicing event 
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in vivo, we engineered a bichromatic splice reporter for Mena11a. If 11a is 
inserted the cells will be red and green, if 11a is excluded the cells will be only 
green. Intravital microscopy experiments on xenografted splice reporter mammary 
cancer cells will allow us to follow the splicing of the intravasating cells and we 
can predict a lack of “11a splicing in” in the these cells. 
 
Mena11a affects the actin cytoskeleton dynamics  
 
Ena/VASP regulates the dynamics of the actin cytoskeleton acting in 
proximity of the barbed end, the growing end of the actin filament. Although there 
is considerable evidence that Ena/VASP proteins act as actin anti capping 
proteins, some controversy remains over their mechanism of action. The general 
idea of anti capping by Ena/VASP proteins is that the proteins permit actin-
filament elongation, even in the presence of high levels of capping proteins. This 
activity is necessary to allow the formation of the long filaments within cells that 
contribute to structures such as filopodia. Ena/VASP supports filopodium 
formation by antagonizing actin filament capping activity (Barzik et al., 2005; 
Bear et al., 2002) and by promoting clustering of filaments at their polymerizing 
ends (Applewhite et al., 2007). However, there is considerable controversy in this 
field, some of which arises from confusion over the definition of anti capping 
activity. The anti capping hypothesis of Ena/VASP function specifically states 
that Ena/VASP proteins associate with elongating actin filaments at or near their 
rapidly growing (barbed) end in such a way as to block the action of capping 
proteins that terminate elongation. It is important to note that this hypothesis does 
not state that Ena/VASP proteins can remove capping proteins that have become 
stably associated with filaments (uncapping) nor does it state that Ena/VASP 
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proteins have any effect on the depolymerization of actin filaments from their 
barbed end (weak capping) nor that Ena/VASP associates processively with the 
growing actin filaments. One final point about this hypothesis is that anti capping 
is not mutually exclusive with other established Ena/VASP functions such as 
filament clustering, bundling or anti-branching. Several types of evidence support 
an anti capping function for Ena/VASP, including in vitro assays with purified 
proteins, structural analysis, cell biological experiments and genetics. Ena/VASP 
anti capping activity has been observed indirectly in pyrene actin polymerization 
assays (Barzik et al., 2005; Bear et al., 2002) and directly in total internal 
reflection fluorescence microscopy (TIRF) assays (Pasic et al., 2008).  
Mena was found overexpressed in invasive cells chemoactratted by EGF in 
in vivo invasion assays (Wang et al., 2004). Forced overexpression of Mena, and 
in particular MenaINV, increases the capacity of cancer cells to migrate in 
response to chemotactic stimuli, invade the surrounding stroma, enter blood and 
lymphatic vessels and metastasize, all actin-dependent properties (Philippar et al., 
2008). We asked whether Mena11a could influence the actin cytoskeleton 
dynamics in carcinoma cells. We overexpressed Mena11a in MTLn3, a mammary 
carcinoma cell line that responds to EGF stimulation protruding with a 
lamellipodia (Chan et al., 1998). This response is mediated by the cofilin pathway 
that leads to the formation of free barbed ends and dendritic network nucleation 
by the Arp2/3 complex. Interestingly, Mena11a damped the EGF-mediated 
lamellipodia protrusion in these cells, while same levels of overexpression of 
Mena significantly potentiated the lamellipodia protrusion. A detailed analysis of 
the lamellipodia leading edge showed that the protrusion of the Mena11a cells are 
often unproductive, while the ones stimulated by Mena are faster and persistent. 
Moreover, the number of Mena11a overexpressing cells collected by in vivo 
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invasion assay was sensibly low compared to the Mena, MenaINV overexpressing 
and control cells, suggesting that a forced expression of Mena11a can suppress the 
invasive potential of these metastatic cancer cells. Importantly, endogenous 
Mena11a is in complex with EGFP-Mena in MTLn3 carcinoma cells. This can 
explain, at least in part, why the overexpression of Mena11a dampens the 
protrusion of these cells. We can hypothesize that the natural compositions of the 
tetramers formed by Mena and Mena11a is unbalanced when Mena11a is 
overexpressed, so that too much Mena11a can deregulate the Mena-dependent 
actin cytoskeleton remodeling, bringing to a suppression of the actin 
polymerization in the cell. Another mechanism that we are currently investigating 
is the suppression of the Arp2/3-mediated branching. Infact, Mena overexpression 
leads to a cytoskeleton with filaments longer and less branched compared to 
control cells in fibroblasts (Bear et al., 2002) and carcinoma cells (Balsamo, not 
shown). The mechanism of this direct effect on branching remains unknown, 
although it is tempting to speculate that Ena/VASP proteins compete with the 
Arp2/3 complex for actin monomers, which are necessary cofactors for branching. 
Alternatively, Ena/VASP proteins might act directly to inhibit branching by 
preventing the docking of the Arp2/3 complex onto the side of a mother actin 
filament. Another possible explanation for the observed anti-branching activity of 
Ena/VASP proteins is through an indirect effect on capping proteins. Dyche 
Mullins laboratory recently described a striking mechanism for controlling the 
frequency of Arp2/3 branching through the capping of barbed ends (Akin and 
Mullins, 2008). They demonstrated that increasing capping activity actually 
increases branching because the levels of actin monomers are locally elevated. 
Anti capping factors such as Ena/VASP proteins could decrease branching by 
reducing of barbed-end capping, which would lead to the increased consumption 
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of monomers through their addition to barbed ends. In this context, different 
Mena isoforms could exert different roles affecting different kinetics of actin 
polymerization.  
Another mechanisms that we found to be potentially important to explain 
the phenotype of the Mena11a overexpressing cells comes from the biochemistry 
of Ena/VASP. The insertion of the 11a exon between the F-actin binding and the 
tetramerization domain inspired us to test whether the insertion could influence 
directly the actin remodeling functions of Mena11a. Using purified proteins, 
biochemical and microscopy based approaches, we have found that the EVH2 
domain of Mena11a, while conserving an actin binding and bundling activity 
(Figure 16), has an impaired barbed ends capture activity compared to the EVH2 
of Mena and VASP (Figure 18). The ability of recombinant VASP to bind the 
barbed end of growing actin filaments has been shown recently by Dorothy 
Schafer laboratory (Pasic et al., 2008). The barbed end capture is a transient 
property since once captured the filaments stop growing for few seconds but then 
get captured by the side and re-start growing. This finding supports the hypothesis 
that transient interactions of Ena/VASP proteins with actin filament barbed ends 
allow this family of proteins to regulate the rate of actin filament elongation, 
barbed end capping and provide a mechanism to recruit filaments barbed ends 
during assembly of specialized actin filaments structures. Of note, the mutation of 
the G-actin binding and the F-actin binding domains in VASP, while affecting the 
F-actin binding, doesn’t affect the barbed end capture activity of the molecule and 
the region between the F-actin and the tetramerization domain was found to be 
sufficient for the barbed end capture (Pasic et al., 2008). Hence, the region 
between the F-actin binding and the tetramerization domain can be a novel site for 
the specific function of binding to the barbed end. The 11a insertion in that region 
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can impair the barbed end capture, and may work as an additional site of 
regulation for Mena-Mena11a tetramers interaction with the barbed end of 
growing filaments. Importantly EVH2-Mena coated surfaces captured the barbed 
ends 10 times more efficiently then EVH2-Mena11a (table 1). Interestingly, the 
barbed end capturing region and the coiled coil domain fold in an unusual right 
handed coiled coil (Kuhnel et al., 2004), similarly of the ends of actin, which also 
folds in a right-handed coil. What can be the fisiological function of the barbed 
end capture? Barbed end capture can be important for filopodia formation and 
initiation, since drugs like cytochalasin D that bind the barbed end of growing 
actin filaments completely abolish the filopodia formation in cells, so the free 
barbed end is needed for the formation of filopodia. We have found that Mena11a 
doesn’t support filopodia formation during cell spreading on laminin, while Mena 
strongly enhances this activity (Applewhite et al., 2007), supporting the 
biochemical data regarding the impaired barbed end capture activity of purified 
Mena11a. 
We also tested the possibility of an impaired anti capping activity by 
Mena11a compared to Mena. The currently data suggest that Mena11a has an anti 
capping activity as strong as Mena by pyrene actin polymerization assays. In these 
assays the actin polymerization is measured by the increase of fluorescence in a 
bulk format such as a cuvette, so the assay doesn’t give information about the 
length or architecture of the actin filaments that are formed. This means that 
several informations regarding the actual actin remodeling cannot be acquired. 
TIRF experiment are ongoing in order to visualize the anti capping property of 
Mena11a compared to Mena, so that we can have more kinetic parameters to 
quantify and compare.    
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In conclusion, my research project focused on the role of a splice isoforms 
of Mena in cancer and epithelial morphogenesis. In particular my findings are 
important to understand why cancer cells need to modify their motility machinery 
during invasion and metastasis. The loss of regulators of epithelial morphology 
can be important for the initial steps of intravasation and subsequent 
extravasation. Mena11a can be considered an important player for these steps in 
the metastatic cascade. 
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